阅读说明：本技术 用于改变膝关节中髌骨与股骨之间的负载及治疗髋关节疾病的设备 (Device for varying the load between the patella and the femur in the knee joint and for treating hip joint diseases ) 是由 维维克·谢诺伊 马克·迪姆 汉森·吉福德 于 2010-08-27 设计创作，主要内容包括：用于改变膝关节中髌骨与股骨之间的负载及治疗髋关节疾病的设备。一种用于改变膝关节中髌骨与股骨之间的负载的设备,髌骨由包括髌骨韧带和股四头肌腱的组织作用在所述股骨上并相对于所述股骨定位,该设备包括：固定部分,该固定部分的配置和大小经过设置,以抵靠胫骨固定在外侧面或内侧面上；跨越区段,该跨越区段的配置和大小经过设置,以从固定部分向头部地延伸；以及移位部分,该移位部分的配置和大小经过设置,以从所述跨越区段向内侧或向外侧、在胫骨髁的中心部分上方和髌骨韧带下方延伸,以使髌骨韧带向前部地移位。(Apparatus for varying the load between a patella and a femur in a knee joint and treating hip joint disease. A device for altering the load between a patella and a femur in a knee joint, the patella being acted upon and positioned relative to the femur by tissue comprising a patellar ligament and a quadriceps tendon, the device comprising: a fixation portion configured and sized to be secured against a tibia on a lateral side or a medial side; a spanning section configured and sized to extend from the fixation portion toward the head portion; and a displacement portion configured and sized to extend medially or laterally from the spanning segment, above a central portion of the tibial condyle and below the patellar ligament to anteriorly displace the patellar ligament.)

1. A device for altering the load between a patella and a femur in a knee joint, the patella being acted upon and positioned relative to the femur by tissue comprising patellar ligament and quadriceps tendon, the device comprising:

a fixation portion configured and sized to be secured against a tibia on a lateral side or a medial side;

a spanning section configured and sized to extend cephaladly from the fixed portion; and

a displacement portion configured and sized to extend medially or laterally from the spanning segment, above a central portion of a tibial condyle and below a patellar ligament to anteriorly displace the patellar ligament.

2. The device of claim 1, wherein the anterior displacement reduces the force with which the patella is pressed against the femur.

3. The device of claim 1, wherein the device is configured and sized to displace the patellar ligament from the pre-treatment anatomical path by a distance in excess of 5mm and less than 30 mm.

4. The apparatus of claim 1, wherein the apparatus is configured to be placed outside the joint capsule with the fixation portion secured to a bone outside the capsule.

5. The apparatus of claim 1, wherein the fixed portion, spanning section, and displacement portion are integral with one another.

6. The apparatus of claim 5, wherein the displacement portion comprises a bearing surface configured to engage a patellar ligament, the bearing surface being a hard and smooth material.

7. The apparatus of claim 1, wherein the displacement portion is configured to be located just cephalad of a tibial tubercle and just caudal of the knee capsule when the fixation portion is mounted to a tibia.

8. The apparatus of claim 1, wherein the displacement portion is configured to avoid the knee capsule when the fixation portion is mounted to a tibia.

9. The apparatus of claim 1, which

The displacement portion includes a bearing surface having a curved ramp shape.

10. The apparatus of claim 1, wherein the displacement portion has a displacement surface configured to redistribute a highest load point between the patella and the femur superiorly, caudally, laterally, or medially, thereby reducing pressure on the surface.

11. The apparatus of claim 10, wherein the bearing surface includes a ridge line on an inner or outer side thereof.

12. The apparatus of claim 10, wherein a first side of the displacement surface is higher relative to the tibia than a second side of the displacement surface.

13. The apparatus of claim 12, wherein the first side is an outer side.

14. The apparatus of claim 12, wherein the first side is a medial side.

15. A device for treating a hip joint condition, the hip joint being subject to forces exerted by soft tissue in the vicinity of the hip joint, the device comprising a prosthesis implantable in position in engagement with the soft tissue so as to displace the soft tissue sufficiently to alter the position, angle or magnitude of the forces exerted by the soft tissue so as to achieve a therapeutic effect on the joint, wherein the prosthesis is configured and dimensioned to alter the forces acting on a dysplastic joint.

16. The apparatus of claim 15, wherein the hip joint is a human hip joint.

17. The apparatus of claim 15, wherein the hip joint is a canine hip joint.

18. The apparatus of claim 15, wherein the prosthesis is implanted on a femur.

Technical Field

The present invention relates generally to the field of orthopedics. In particular, the present invention relates to an interventional technique and an implant for redistributing forces within a joint for therapeutic purposes.

Background

There are many joints in the human body to connect bones to each other to varying degrees. Those joints that achieve free articulation are called dynamic joints. Such as the hip, knee, elbow and shoulder joints. There are a variety of connective tissues associated with the joint, including the articular cartilage that provides a shock absorbing and smooth sliding surface, the ligaments that provide a flexible connection between the bones, and the tendons that slide over the joint and connect the muscles to provide motion. If the connective tissue is damaged, joint pain and loss of function can result.

One example of damaged connective tissue is knee osteoarthritis, i.e., knee OA. Knee joint OA is one of the most common causes of disability in the united states. OA is sometimes referred to as degenerative arthritis or abrasion-tear arthritis. The knee joint is formed by connecting the femur, patella and tibia (see fig. 3). Like other freely connected joints, the knee joint is surrounded by a fibrous joint capsule lined with synovium. The inner surface of the patella is engaged with the femoral surface to form the patellofemoral joint. The end of the femur has two curved articular surfaces, called the medial and lateral condyles. These articular surfaces connect with the medial and lateral tibial condyles to form a tibiofemoral joint, allowing flexion and extension of the knee joint. Two fibrocartilaginous discs (i.e., menisci) are provided between the tibial and femoral condyles to compensate for the incompatibility of the articular bones. Because the shape of the distal femur is curved and asymmetric, the knee joint not only flexes and extends like a hinge, but also slides and rotates during flexion, thereby imparting complex motion to the joint.

Knee joint OA is characterized by damage to the articular cartilage within the joint. Over time, the cartilage may wear away completely, causing bony contact. Since bone has many nerve cells unlike cartilage, direct bone-to-bone contact causes great pain to OA patients. In addition to pain and swelling, OA patients gradually lose mobility in the knee joint. This is because the joint space is reduced because the articular cartilage has been completely worn. Generally speaking, OA generally affects the side of the knee joint that is closer to the other knee joint (called the medial compartment) and less so the exterior (the lateral compartment). The bent leg position will also exert a greater pressure on the medial compartment than normal. This increase in pressure will cause more pain and faster degeneration as the cartilage is squeezed together.

Various medications are often recommended to reduce swelling and pain in OA. Other treatments such as weight loss, scaffolding, orthotics, steroid injections, and physical therapy may also help to reduce pain and restore function. However, the recovery and growth of cartilage in adults is minimal due to the avascularity or lack of blood supply to the articular cartilage. If it is too painful or immobile and other therapies fail to alleviate the symptoms, surgery is required. In some cases, surgical treatment of OA is appropriate. Surgery includes arthroscopic therapy to clean the joint by removing loose pieces of cartilage and by flattening rough spots on the cartilage; various kinds of operations have been performed in total knee replacement using an artificial knee joint.

Another surgical treatment for OA in the knee joint is proximal tibial osteotomy (proximal osteotomy), which is intended to realign angles in the lower leg to help transfer pressure from the medial to the lateral side of the knee joint. The aim is to relieve pain and further delay the degeneration of the medial compartment.

In a proximal tibial osteotomy, the upper part (proximal) of the tibia is cut and the angle of the joint is changed. This converts the bending leg into a knee joint that is either straight or slightly everted. By correcting joint deformities, the pressure of the cartilage is reduced. However, proximal tibial osteotomies are only temporary and eventually require total knee replacement. With successful surgery, the therapeutic effect can last for five to seven years. The advantage of this approach is that very active patients will still be able to retain their own knee joint and after bone healing there will be no restriction on the activity.

Another connective tissue disorder that occurs in the knee joint is excessive Patellar Compression Force (PCF). For patellofemoral arthritis patients, excessive patellar pressure can cause pain and lead to cartilage degradation between the patella and the femur.

Current treatment methods to mitigate excessive PCF in such patients include highly invasive osteotomies to reposition the point of attachment of the patellar tendon on the tibia. One such therapy is the Maquet therapy, which advances the tibial tuberosity by resecting a portion of the bone and repositioning the bone with a graft bone inserted beneath the bone. Advancing the point of attachment of the patellar tendon reduces the overall PCF by changing the moment arm and effective angle of the force. However, this therapy is highly invasive, has a high surgical incidence and significant rehabilitation, which can be challenging for some patients. Even if some therapies were initially successful, the lack of rehabilitation compliance can reduce positive outcomes.

In addition to the Maquet osteotomy, other tibial tuberosity therapies, such as the Fulkerson osteotomy and the elmslee-Trillat osteotomy, also reduce pressure on the patella by displacing the patellar tendon. These osteotomies also redistribute the load on the patella by transferring the load to other regions of the patella. Similarly, these alternatives have a relatively high surgical incidence and significant healing effects.

Another example of joint pain and loss of function due to damage of connective tissue is hip dysplasia. The hip joint is the deepest and largest joint in the body and is formed between the femoral head and the acetabulum of the pelvis (see fig. 27). The hip joint is used primarily to support the weight of the body when in static positions (e.g., standing) and dynamic positions (e.g., running and walking).

Hip dysplasia refers to a congenital or acquired deformity or dislocation of the hip joint. The symptoms of the disease are relatively mild and almost undetectable, and severe with severe deformities or dislocations. Early hip dysplasia is usually treated with the use of the Pavlik harness (Pavlik hardess) or the Freka pillow or the occipital clip (Frejka pillow or spline). For slightly larger children, surgical treatment is necessary because the hip abductor and ilio-lumbar muscles have accommodated the dislocated joint position. Relatively small years of age, hip dysplasia is commonly recognized as the cause of hip Osteoarthritis (OA). Misalignment of the bearing surfaces can lead to increased wear and anomalies. Subsequent treatment with total hip replacement is complicated by the fact that the skeleton will change as the body matures, thus requiring revision surgery.

Current treatments for dysplasia-related pain are femoral neck osteotomies or periacetabular osteotomies. For more complex cases, only total hip replacement surgery is the surgical option. In both cases, treatment involves extensive surgery and long-term rehabilitation procedures. Thus, there is a need for a less invasive yet effective method of treatment.

Joint pain and loss of function due to damage of connective tissue is not limited to humans. For example, the high frequency of canine hip dysplasia has brought canine hip joint focus of attention to veterinary orthopaedic surgeons. Canine hip dysplasia begins to manifest in a typical manner with reduced mobility, with varying degrees of joint pain. Typically, these symptoms are first observed between four months of age and one year of age.

In a normal canine hip joint, the femoral head fits in an congruent manner in the acetabulum (see fig. 61A-61B). In dysplastic joints, the femoral head has poor conformity with the acetabulum. The space between the bones is more pronounced. Femoral head displacement is a characteristic of the disease. For human joint malposition, a number of surgical procedures have been devised to treat joint dysplasia-femoral head osteotomy, intertrochanteric osteotomy (ITO), Triple Pelvic Osteotomy (TPO), and total hip arthroplasty. Thus, there is also a need for less invasive solutions for joint malposition conditions and diseases in dogs, as well as other veterinary applications.

Given the long-term ineffectiveness of current non-surgical treatments and the significant damage of current surgical treatments, there is a need to provide an alternative to significantly reduce the surgical morbidity and rehabilitation requirements for patients with early and developing symptoms of joint disease associated with damaged connective tissue, such as hip dysplasia and lateral knee and patellofemoral osteoarthritis.

Disclosure of Invention

The present invention uses selectively placed grafts to treat joint pathologies due to misdistribution of forces. By using appropriately sized and positioned implants as described herein, targeted connective and muscular tissue surrounding the joint is displaced to realign force vectors and/or change the moment arm loading the joint, thereby achieving therapeutic goals with minimal connective tissue resection and no bone resection.

Indeed, the various embodiments of the present invention may be applied to any joint, including but not limited to knee and hip joints. In addition to the described implants and associated prostheses and devices, various embodiments of the present invention include methods of treating joint disease, and methods of installing implants and prostheses for less invasive joint treatment.

In one exemplary embodiment of the invention, an apparatus for treating a joint to achieve a force distribution in the joint is disclosed. The exemplary device is for treating a joint comprising at least first and second bones having opposing articular surfaces, wherein the bones are positioned relative to each other by associated muscle and connective tissue. These tissues include the target tissue to be treated with the device. Such an exemplary apparatus may include a support member having a support surface disposed thereon. The support member is configured and dimensioned for placement in a treatment position adjacent at least one of the target tissues, and the support member has a thickness sufficient to displace the target tissue from its natural path to the treatment path when placed in the treatment position. A support surface disposed on the support member is configured to engage the target tissue in a non-invasive manner and to allow the target tissue to move along the support surface. The specific structure, configuration, size, and fixed modality will be described in detail below.

In another exemplary embodiment of the invention, a method for treating a joint to achieve a force distribution in the joint is disclosed. The exemplary method is suitable for treating a joint comprising at least first and second bones having opposing articular surfaces, wherein the bones are positioned relative to each other by associated muscle and connective tissue. The exemplary method comprises: selecting at least one of the associated muscle tissue and connective tissue as a target tissue for treatment; displacing a target tissue without severing bone or the target tissue; and redistributing the load in the joint to achieve therapeutic goals through displacement. Alternative and more specific methods are described in detail below.

In another exemplary embodiment of the invention, a device for altering the load between a patella and a femur in a knee joint, the patella being acted upon and positioned relative to the femur by tissue comprising a patellar ligament and a quadriceps tendon, the device comprising: a fixation portion configured and dimensioned to be secured against the tibia on the lateral side or the medial side; a spanning section configured and sized to extend from the fixation portion toward the head portion; and a displacement portion configured and sized to extend medially or laterally from the spanning segment, above a central portion of the tibial condyle and below the patellar ligament to anteriorly displace the patellar ligament.

Wherein the anterior displacement reduces the force with which the patella is pressed against the femur.

Wherein the device is configured and sized to displace the patellar ligament from the pre-treatment anatomical path by a distance in excess of 5mm and less than 30 mm.

Wherein the device is configured to be placed outside the joint capsule with the fixation portion secured to bone outside the capsule.

Wherein the fixing portion, the spanning section and the displacement portion are integral with one another.

Wherein the displacement portion comprises a bearing surface configured to engage with a patellar ligament, the bearing surface being a hard and smooth material.

Wherein, when the fixation portion is mounted to the tibia, the displacement portion is configured to be located just cephalad of the tibial tubercle and just caudal of the knee capsule.

Wherein the displacement portion is configured to avoid the knee capsule when the fixation portion is mounted to a tibia.

Wherein the displacement portion comprises a bearing surface having a curved ramp shape.

Wherein the displacement portion has a displacement surface configured to redistribute a highest load point between the patella and the femur superiorly, caudally, laterally or medially, thereby reducing pressure on the surface.

Wherein the bearing surface comprises a ridge line on its inner or outer side.

Wherein the first side of the displacement portion is higher relative to the tibia than the second side of the displacement surface.

Wherein, the first side face is an outer side face.

Wherein the first side is an inner side.

In another exemplary embodiment of the invention, an apparatus for treating a hip joint disorder is disclosed, the hip joint being subject to a force exerted by soft tissue adjacent the hip joint, the apparatus comprising a prosthesis implantable in engagement with the soft tissue so as to displace the soft tissue sufficiently to alter the position, angle or magnitude of the force exerted by the soft tissue to achieve a therapeutic goal for the joint, wherein the prosthesis is configured and dimensioned to alter the force applied to a dysplastic joint.

Wherein the hip joint is a human hip joint.

Wherein the hip joint is a canine hip joint.

Wherein the prosthesis is implanted on a femur.

Drawings

For the purpose of illustrating the invention, the drawings depict aspects of one or more exemplary embodiments of the invention. It should be understood, however, that the present invention is not limited to the precise arrangements and instrumentalities shown in the attached drawings, wherein:

fig. 1 is an outside view of a knee joint, partially cut away, depicting connective tissue and muscles associated with the knee joint, and a schematic example of a graft according to an embodiment of the invention.

Figure 2 is a rear view of a right knee, partially cut away, depicting connective tissue and muscles associated with the knee joint, and a schematic example of a graft according to a further embodiment of the invention.

Fig. 3 is a front, i.e., frontal view of the bones of the right knee joint.

Fig. 4 is a schematic diagram depicting a human gait cycle, knee joint moments and angles of flexion within the gait cycle relative to an exemplary embodiment of the invention, and the schematic diagram includes a sequence diagram depicting the location of connective tissue in the gait cycle.

Fig. 5 is a free body diagram depicting forces acting on a normal knee joint during a portion of a gait cycle.

Fig. 6 is a free body diagram depicting forces acting on a knee joint that is medially overloaded.

Fig. 7 is a free body diagram depicting forces acting on a knee joint having an implant according to an exemplary embodiment of the present invention.

Fig. 8 and 8A are a perspective view and a cross-sectional view, respectively, of a soft, conformable prosthesis according to an exemplary embodiment of the present invention.

Fig. 9 is an anterior schematic view of a prosthesis implanted femoral tip according to an exemplary embodiment of the present invention.

Fig. 10 is an anterior schematic view of a prosthesis implanted femoral tip according to an alternative exemplary embodiment of the present invention.

Fig. 11, 12, 13A and 13B are plan views of prostheses according to alternative exemplary embodiments of the present invention.

Fig. 14 is a sectional view taken through line 14-14 of fig. 11, depicting a supporting/displacing portion of the prosthesis according to another exemplary embodiment of the invention.

Fig. 15 is a front view of a right knee joint implanted with a prosthesis according to an exemplary embodiment of the present invention.

Fig. 16, 17A, 18 and 19 are side schematic and detail views of a further alternative embodiment of the invention provided with an adjustable support member.

FIG. 20 is an anterior view of a human knee joint depicting another exemplary embodiment of the present invention positioned for treating lateral force distribution in the knee joint.

Fig. 21 is a diagram of a knee joint with a trans-articular prosthesis according to another exemplary embodiment of the present invention.

Fig. 22 is a free body diagram of a human knee joint during stair climbing.

Fig. 23A is a free body diagram of a human knee joint depicting the resultant patellar compression force in a normal knee joint.

Fig. 23B is a free body diagram of a human knee joint depicting the resultant compressive force after modification by an exemplary embodiment of the present invention.

FIG. 24 is a sagittal cross-section of a human knee joint having an exemplary embodiment of the present invention implanted therein for reducing patellar pressure.

Fig. 25 is a front view of a human knee joint depicting the exemplary embodiment of fig. 24 positioned beneath connective tissue.

FIG. 26 is a front view of a human knee joint depicting positioning of a further exemplary embodiment of the present invention for treating lateral force distribution and patellar pressure placed below connective tissue.

FIG. 27 is an elevation view of the right side of the hip joint depicting the attachment of the hip joint to the femur with ligaments omitted to show detail.

Figure 28 is a posterior view of the hip joint of figure 27 with the ligaments in place.

Fig. 29 is a posterior view of the hip joint, depicting the gluteus muscles, particularly the gluteus maximus and gluteus medius.

Fig. 30 is a posterior view of the hip joint of fig. 29 depicting the lower muscles of the right hip joint.

Fig. 31 depicts the forces exerted on the hip joint.

Fig. 32A, 32B, and 32C depict the effect of the femoral angle on the force exerted on the hip joint.

Fig. 33A and 33B are cross-sectional views of a hip joint with a prosthesis installed according to an exemplary embodiment of the present invention.

Fig. 34A and 34B are force diagrams depicting the effect of the prosthesis of fig. 33A-33B on hip abduction muscle strength according to an exemplary embodiment of the present invention.

Fig. 35 depicts a prosthesis anchored to a femur and pelvis in accordance with an exemplary embodiment of the present invention.

Fig. 36 depicts a prosthesis according to an exemplary embodiment of the invention comprising two lamellae for the femoral side of the prosthesis.

The exemplary prosthesis shown in fig. 37 is similar to the prosthesis in fig. 36, but without the anchoring structures.

Fig. 38 is a front view of an example prosthesis installed in a hip joint according to another exemplary embodiment of the present invention.

Fig. 39 shows the prosthesis of fig. 38 with the ligament and the abductor muscle omitted.

Fig. 40 depicts a dog bone prosthesis extending laterally to the femoral neck according to a further exemplary embodiment.

Fig. 41 depicts a kidney shaped prosthesis extending laterally to a femoral neck according to one embodiment.

Fig. 42 depicts the prosthesis mounted on a U-shaped bracket that extends around the femoral neck according to one exemplary embodiment of the present invention.

Fig. 43 depicts a prosthesis mounted as a cover on a large rotor according to another exemplary embodiment of the present invention.

Fig. 44 depicts a prosthesis according to an exemplary embodiment of the invention comprising a recess or channel for receiving a hip abductor muscle.

Fig. 45 depicts a prosthesis according to an exemplary embodiment of the invention comprising an external roller for rolling the hip abductor over the prosthesis as the femur moves.

Fig. 46, 47, 48 and 49 depict another example of a prosthesis comprising two legs connected by a hinge.

Fig. 50 depicts a prosthesis according to a further exemplary embodiment of the present invention having two hinged elements, each having a first and a second crescent-shaped leg connected by a hinge, wherein the two hinged elements are nested together.

Fig. 51 depicts the prosthesis of fig. 50 mounted on a large rotor.

Fig. 52 depicts a strap according to an exemplary embodiment of the present invention extending around the femoral neck and hip abductor muscles.

Fig. 53, 54, 55, and 56 depict examples of cinching mechanisms that may be used with the strap of fig. 52 in accordance with exemplary embodiments of the present invention.

Fig. 57 depicts an alternative connection of a prosthesis, wherein the prosthesis is connected to hip abductor muscles via a band.

FIG. 58 is a front view of a human hip joint fitted with a replacement implant according to an alternative embodiment of the present invention.

Fig. 59 is an outside view of the embodiment shown in fig. 58.

Fig. 60 is a side view of the implant shown in fig. 58 and 59.

Figures 61A and 61B are lateral and anterior views, respectively, of the right hind limb and hip joint of a dog.

Figure 62 depicts the vertical force applied at the canine hip joint during normal gait.

Fig. 63 depicts the relative orientation of the femur and pelvis in the hind limb of a dog during the stance phase of the gait cycle.

Figure 64 is a free body diagram depicting the static and moment forces exerted on the posterior hip joint of a dog when standing on three legs.

Figure 65 is a front view of a canine hip joint including an implant according to an exemplary embodiment of the present invention.

Figure 66 is a free body diagram depicting a modification of the biomechanics of a canine hip joint including an implant according to an embodiment of the present invention.

Fig. 67 is a simplified flow diagram of a treatment protocol according to an exemplary embodiment of the present invention.

Fig. 68 is a graph of simulation results.

FIG. 69 is a graph of another simulation result.

Detailed Description

Imbalances in the distribution of forces in joints, which can lead to or exacerbate joint disease, can be addressed in embodiments of the present invention by employing interventional techniques involving redistribution of forces exerted on the joints without the need for highly invasive surgery causing severe damage to the joints and associated muscles and connective tissue. In certain embodiments of the invention, increased force may be selectively applied to one side of a joint by displacing selected muscles and/or connective tissue (target tissue) around a longer or more inclined path, thereby increasing the amount of force exerted by such muscles or tissue on the joint, changing the effective direction and/or moment arm of the force. This can be accomplished, for example, by appropriately shaping the graft and placing it under the selected target tissue in a relatively non-invasive manner compared to current procedures for addressing such diseases.

In a more specific example of an embodiment of the invention, for certain applications of the knee joint, it is proposed to place one or more implants below selected target tissues so that the lever used by the muscle forces acting on the joint can be varied to positively affect joint loading. For knee osteoarthritis, such target tissue may include muscles, tendons, or ligaments on the outside of the joint that can react to medial forces and reduce excessive contact of the medial articular surfaces. As shown in fig. 1 and 2, such prostheses may be placed beneath target tissues including, but not limited to, the biceps femoris tendon (grafts 10A and 10B), the iliotibial band or tensor fascia latae (graft 10C), the lateral quadriceps patellar tendon (graft not shown), the lateral gastrocnemius (graft not shown), the popliteal muscle, or the fibular collateral ligament (graft 10E), thereby displacing the relevant muscle/tendon/ligament laterally. The treating physician can readily identify other target tissues based on the particular anatomy of the patient and the indication to be treated.

In other exemplary embodiments particularly applicable to hip joints, the prosthesis is disposed on the surface of the hip capsule, but below the hip abductor muscle group, to alter the force vector provided by the hip abductor muscle. For example, as shown in fig. 33A-33B, such a prosthesis (graft 220) may be placed or arranged under any one or a combination of a plurality of abductors to obtain a desired resultant force vector. Any muscle involved in hip abduction may be the target tissue, including gluteus medius GMed, gluteus minimus GMin, psoas, piriformis PIR, tensor fascia latae, quadratus lumborum, and rectus femoris. In various embodiments, the prosthesis will be placed in the tissue between the gluteus muscles and ligament L, but the prosthesis may be placed in other locations as well.

Advantageously, implants according to embodiments of the present invention may be placed outside of the joint capsule in order to minimize the risk of interference with joint function and infection and other problems associated with the placement of foreign objects within the joint capsule. In addition to alleviating pain and possibly altering the progression of joint degeneration, placing the prosthesis under the lateral target tissue can also reduce the lateral laxity of the joint. The capsule associated with the target tissue may be a candidate location for such a graft, and may be displaced or moved and replaced by the graft. Precise placement at the location of the capsule is not required and implants according to embodiments of the invention may also be placed at locations remote from the associated capsule, depending on clinical performance.

Before addressing more details of exemplary embodiments of the present invention, it may be helpful to have a basic understanding of the first example, joint biomechanics in the knee joint. As shown in fig. 3, the knee joint includes four bones: the top femur, the inferior fibula and tibia, and the patella located in the medial anterior. Lower extremity varus and valgus (defined by the tibia from the knee to the ankle) are commonly referred to as the snare leg (varus) and the inner octagon (valgus), respectively.

Since the gait cycle has a key effect on the joint load, the normal gait cycle of a human will now be described with reference to fig. 4. The gait cycle begins when one foot contacts the ground (a) and ends when that foot again contacts the ground (G). Thus, each cycle begins at the initial touchdown of the stance phase, through the entire swing phase, until the end of the next initial touchdown of the limb. (note that the description of the gait cycle refers to the movement of the leg shaded black in fig. 4).

In a single gait cycle, the stance phase accounts for about 60% and the swing phase accounts for about 40%. Each gait cycle includes two phases with both feet on the ground. The first phase of dual limb support begins at initial touchdown and lasts for the first 10% to 12% of the cycle. The second phase of dual limb support occurs at the last 10% to 12% of the stance phase. When the standing limb is ready to leave the ground, the opposite limb contacts the ground and bears the weight of the body. The two phases of dual limb support account for 20% to 24% of the total duration of the gait cycle.

When at rest or in both stance phases of gait (a to B and D to E in figure 4), weight is borne on average by both feet, the force through the knee joint is only a small fraction of the body weight, and there is no bending moment around both knees. However, knee joint forces are greatest when body weight is transferred to a single leg (B to D).

The resultant forces experienced by a healthy knee joint when standing on one leg are shown in the free body diagram of fig. 5, where x represents the medial (varus) lever arm; y represents the lateral lever arm through which the lateral structure of the knee operates, P represents the weight supported by the knee, and R represents the resultant joint reaction force. Thus, the leg normally tends to evert slightly from the vertical, and the plumb line to the center of gravity will fall from the medial side of the knee joint to the center of the knee joint.

This arrangement of forces exerts a bending moment on the knee joint acting through the medial lever to open and invert the knee joint, in other words, to open the lateral side of the joint. With one leg standing at rest and the knee fully extended, the lateral muscles, tendons, ligaments and bursa are tight. These structures resist the inward bending moment that is lever-operated on the inside. In dynamic situations during gait, multiple muscles in the center of the joint or outside the center combine to provide lateral resistance to prevent the lateral side of the joint from opening due to the medial lever. These include the forces exerted by the target tissue, such as the quadriceps patellar tendon, lateral gastrocnemius, popliteal, biceps and iliotibial band (see fig. 1 and 2), which are manipulated by lever arm y, and are represented by L in fig. 5. This combination determines the magnitude and direction of the resultant force vector R of the tibial-femoral joint load. In a healthy knee, this resultant force vector is approximately midway between the lateral and medial condyles.

As the genu varus angle increases, the medial lever arm increases, requiring more lateral counter force L to prevent the joint from being overloaded medially. If the forces causing the knee joint to enter the varus state reach a threshold level, as shown in fig. 6, the compensatory ability of the associated connective tissue in its natural state is overcome, and as a result, the joint load R is taken up by the medial compartment, resulting in excessive wear and, ultimately, possibly, severe pain to the joint. This condition can lead to knee osteoarthritis.

The situation illustrated in fig. 6 may be addressed in accordance with an embodiment of the present invention by altering the position of the target tissue acting on the joint in order to adjust one or more of the force magnitude, angle, and/or moment arm. Thus, as described above, in exemplary embodiments, one or more grafts are placed under a selected target tissue to advantageously alter the force distribution by increasing the lateral moment (counterclockwise in the figures).

FIG. 7 illustrates an exemplary embodiment of the present invention in which a universal implant 10 according to one embodiment is placed along a joint to help redistribute forces acting on the joint for therapeutic purposes. As shown, the implant 10 creates a space near the joint that allows the target tissue (not shown) that travels along the joint to take a longer path over the implant surface. The longer path may produce a number of benefits, including increasing the outer moment arm y ', moving the line of action of the target tissue to a more effective angle, and/or tensioning the target tissue to increase the amplitude of the force vector L'. Thus, the effective outboard moment is increased, thereby more effectively reacting the inboard moment created by the supported weight P. This moves the joint load R laterally out of the medial compartment and back to a more normal central position. Implant 10 may take a variety of forms, as discussed in more detail below with respect to various exemplary embodiments of the present invention.

The amount of displacement of the target tissue need not be so great as to have a substantial effect on increasing the outboard torque to help unload the inboard compartment. For example, the normal lateral lever arm (y) of a typical human is about 50 millimeters. Thus, an increase in outboard torque of about 20-30% can be achieved by just increasing the outboard displacement of the lever arm (y') by about 10-15 mm. Depending on the geometry of the particular patient's joint, the lateral displacement may be between about 5mm to about 30mm, with the most typical range of displacement being from about 10 mm to about 30mm, or specifically, about 10 mm to 20 mm.

Examples of the invention

To assess the load change in the medial compartment of the knee due to lateral displacement of the target tissue, simulations can be performed using a computational model of the knee to determine an approximate percentage reduction in medial contact force. (for details of the computational model, see Lin (Lin), Y. -C, Walter (Walter), J.P., Banks (Bank), S.A., Pandy (Pandy), M.G., and Fregley (Fregly), B.J.)"Simultaneous prediction of muscle and contact forces in the knee joint during gait (Simultaneous) Prediction of Muscle and Contact Forces in the Knee During Gait)”Pages 945 to 952, Journal of Biomechanics 2010(Journal of biomemechanics 2010), incorporated herein by reference. Calculating the medial contact force at two points in the gait cycle, with the greatest medial contactThe force (about 15% and 50% of the gait cycle at peak 1 and peak 2, respectively) varies with displacement of the lateral knee muscle. The lateral muscles are displaced 0mm to 35 mm in 5mm increments as described in connection with the embodiments of the invention. In this simulation, the starting ends of three lateral knee muscles (tensor fasciae latae, biceps femoris long head and biceps femoris short head) were displaced laterally from the femur without changing the insertion positions of these muscles. The results of these simulations are shown in graph 1 in fig. 68, which shows that the average inboard load can be reduced by up to about 12% with a displacement of about 35 millimeters, according to an embodiment of the present invention.

A simulation was also performed for absolute medial contact force, where the origin of the lateral muscle was displaced by about 30mm, as a function of percent stance phase. In this simulation, the starting ends of three lateral knee muscles (tensor fasciae latae, biceps femoris long head and biceps femoris short head) were displaced laterally from the femur without changing the insertion positions of these muscles. The results of this simulation are shown in graph 2 in FIG. 69, which shows that the inboard contact force is generally reduced over the range of motion simulated by the embodiments of the present invention. In the simulated case, a force reduction in the range of about 100N may be achieved at various points in the gait cycle. Graph 2 also depicts the medial contact force without a graft. The substantially upper non-displaced line represents the simulation without the implant, while the substantially lower displaced line represents the simulation with the implant.

The configuration and manner of securing the implant according to embodiments of the present invention may be varied, as described in more detail below with respect to exemplary embodiments. In general, such implants may be rigid, semi-rigid, or soft conformable prostheses that are secured to adjacent bone or surrounding tissue. The implant can also be held in place by surrounding tissue without the use of fixation elements. Soft fitting prostheses may be filled with water, saline, silicone, hydrogel, etc., which is sufficient to move tissue laterally outward, as described above. Such soft, conformable prostheses can be placed in a deflated state and then expanded to an appropriate thickness. Alternatively, the implant may be filled with other flowable materials, including beads or other particles of metal, polymer, or foam material that may be selectively placed in a liquid medium, the flowable materials conforming to the adjacent bone or tissue surface. Thixotropic materials such as hydrogels derived from hyaluronic acid can change mechanical properties when shear stress is applied. Implants filled with such materials can alter lateral displacement, wherein the lateral displacement is created based on shear stresses experienced by the lateral side from overlying target tissue at various points in the gait cycle. The graft may be coated with a material to reduce friction, such as a hydrophilic coating or a Polytetrafluoroethylene (PTFE) coating. Additionally or alternatively, the prosthesis may be adapted so as to enable adjustment of dimensions, such as the thickness of the prosthesis, at any time during or after the operation. Rigid or substantially rigid prostheses may be made from known bone-compatible graft materials, such as titanium or stainless steel. Whether a rigid material or a suitable material, the surface of the prosthesis should be designed to minimize the negative effects of connective tissue moving over it. Such implants may be implanted by arthroscopic therapy, or using small incision or incisional surgical methods.

Fig. 8 illustrates an exemplary embodiment of a soft compliant implant. In this embodiment, the implant 20 includes a body member 22 made in whole or in part of a soft conformable material as described above. The body member 22 has an upper (outwardly facing) bearing surface 21 configured to slidingly engage with a target tissue to be displaced. The support surface 21 thus forms a displaced part of the implant. The bearing surface is preferably made of or coated with a lubricious material such as PTFE or a hydrophilic material to reduce friction with the target tissue. The body member 22 is further shaped to enhance its ability to maintain a desired position relative to the target tissue. In this regard, the body member 22 has a generally glass-like shape with a thinner and narrower central section 24 and a wider and thicker end section 26 to conform to the contours of the target tissue. Preferably, the body member 22 is shaped such that the upper bearing surface 21 forms a groove or channel to guide and secure the target tissue on the bearing surface as the target tissue slides relative to the bearing surface. Thus, the outer edges of the body member 22 may be thicker than the middle, or the outer edges may be curved or bent upward to prevent the target tissue from sliding off the edges of the body member 22. The body member 22 has a preferred shape to slide under the target tissue and to secure itself in place by pressure between and friction with adjacent tissue without the need for separate fasteners. If desired, the underside (opposite the upper bearing surface) may have friction enhancing features, such as bumps, scales or protrusions, that engage underlying tissue to increase retention to form the fixation section. Still alternatively, to further secure the graft in the desired position, attachment means for fasteners such as sutures or straps, such as holes 28, may be provided on one or both ends of the body member 22, or a flexible strap or band 29 configured to wrap around the target tissue may be coupled to or integral with the upper or lower end of the body member 22. In one exemplary embodiment, an implant configured generally in the manner of implant 20 may be particularly suitable for insertion under the illiotibial band.

In another exemplary embodiment of the invention, as shown in FIG. 9, the prosthesis 30 is displaced laterally by inserting a passive and space-consuming implant beneath the target tissue. The prosthesis 30 includes a main body member 32 having a displacement portion 33 and a fixation portion 34. The displacement portion 33 is a portion for displacing the target tissue as needed to redistribute the force. The medial surface of the displacement portion 33 has a preferred shape to conform to the external shape of the lateral femoral condyle and may have a hook-shaped or scoop-shaped tip to wrap partially around the distal surface of the lateral femoral condyle. The outer side of the displacement portion 33 is preferably rounded and smooth to provide a smooth sliding surface for the displaced soft tissue. The fixation portion 34 is shaped so as to lie more evenly under the muscles and tendons above the femur and avoid complex areas adjacent the femoral condyles where there can be many different tissue intersections and connections to the bone. This more cephalad section of the femur provides easier access to the underlying bone and may result in better fixation. Fixation may be achieved using any known means for bone fixation implants, such as bone screws 36, staples, anchors, or adhesives, to name a few. The implant may be made of any suitable hard or soft material. In this case, silicone, titanium, stainless steel or pyrolytic carbon of varying grades and hardness are examples of suitable materials.

In an alternative embodiment, it may be desirable to fix the prosthesis directly to the femur in the condylar region, depending on the patient's particular circumstances. The prosthesis 40 shown in fig. 10 is an example of such a prosthesis. In this embodiment, the fixation and displacement portions are juxtaposed in the body member 42 at a location closer to the femoral condyle. The configuration of the body member with respect to its displacement function is substantially the same as described above. The fixation is also substantially the same as described above, e.g. the illustrated screw 44, except that it is adapted to juxtapose the fixation function and the displacement function.

In alternative embodiments, the displacement portion and the fixation portion of the prosthesis of the present invention may be of unitary construction, or may be formed of two or more portions, depending on the desired function. For example, the fixation portion may be constructed of stainless steel or titanium to encourage bone ingrowth and secure with screws, while the bearing/displacement portion may be made of a different material, such as pyrolytic carbon, to enhance the ability of the underlying tissue to slide over the implant, or PTFE, silicone or other low friction polymer with appropriate wear characteristics to provide a softer bearing surface. In other alternatives, the displacement portion may be comprised of a substrate of one material, with an overlying layer forming the support material. The substrate may be connected to or adjacent to the fixed part.

The fixed portion and the displaceable portion may be in line with each other, or may be offset from each other, or may be combined, having a plurality of displaceable portions. Alternative exemplary embodiments of this aspect are shown in fig. 11 through 13B. For example, the prosthesis 50 in fig. 11 includes a base member 52 configured to place a displacement portion 53 on the anterior side relative to a fixation portion 54. Therefore, the base member 52 generally has: a linear section configured to be mounted to a femur; and a curved section extending from the straight section to the anterior side upon implantation. The displacement portion 53 is connected to the curved section and extends below so as to be located below the target tissue adjacent to the lateral femoral condyle. In this embodiment, one or both of the inside and outside surfaces of the displacement portion 53 may have a bearing surface 56 thereon, the bearing surface 56 being constructed of a different material and having a lower friction than the remainder of the bearing portion 53. Alternatively, the base member 52, the displacement portion 53 and/or the bearing surface 56 may be the same material and may be of unitary construction. Fixation holes 58 are provided in the fixation portion to receive screws for attachment to bone.

The prosthesis 60 provides another exemplary embodiment, as shown in FIG. 12, which includes a base component 62 having a spanning section 61 between a displaced portion 63 and a fixed portion 64. The securing hole 68 is again provided as an alternative securing member and a separate bearing surface 66 may be provided. Alternatively, the base member 62 and the displacement portion 63 may be the same material and may be of a unitary structure. In this embodiment, spanning section 61 extends generally vertically between fixed portion 64 and displaced portion 63, and is offset posteriorly relative to fixed portion 64 and displaced portion 63, thereby avoiding critical anatomical features adjacent the joint. Depending on the particular joint anatomy and patient condition, the spanning section may secure the fixation portion in place while still positioning the displacement portion below the target tissue while minimizing trauma to critical intervening tissue.

In yet another exemplary embodiment, a plurality of shift portions may be provided as shown in fig. 13. For example, the prosthesis 70 includes a base portion 72 having an anterior displaced portion 73A and a posterior displaced portion 73B. These portions are joined by a spanning section 71 to a fixing area 74 provided with fixing holes 78. In this embodiment, the displacement portions 73A and 73B each include a bearing surface 76. Also, the bearing surface may be integral with or connected to the base member. Moreover, in this embodiment or any other embodiment herein, the displacement portions 73A, 73B may be movably coupled to the span segment 71 or the fixed area 74 by a rotatable or slidable coupling 75, e.g., as shown in fig. 13A, so as to be movable with articulation. Alternatively, the spanning section 71 or the junction between the portion and the displacement portion may include a flexible portion 77 to deflect in response to joint movement, as shown in FIG. 13B. In a further alternative, the flexible portion 77 may be malleable, thereby allowing the surgeon to deform and/or reposition the displaced portions 73A, 73B to a desired configuration before or after the prosthesis has been secured in place. In yet another alternative, the couplings between the displacement portion and the span segment 71, or the span segment and the base component 72, may be movably adjustable, thereby allowing the surgeon to position the components in different positions relative to each other and fix the components in any such position.

As described above, the displaced portion of the prosthesis according to embodiments of the present invention may have a variety of different shapes as desired to fit the specific target tissue required for the particular patient's pathology. In further examples, more complex geometries may be provided to adapt to the gait cycle of the patient and the loading conditions during that cycle to alter target tissue displacement. For example, the bearing surface may be configured to achieve relatively less tissue displacement and force realignment when the knee joint is flexed in a gait cycle, but to deflect the target tissue to a greater extent when the knee joint is fully deployed in a gait cycle, thereby providing the necessary treatment appropriate to the pathology. This feature can be achieved by: optimizing the static geometry of the graft; dynamically varying implant position or geometry with joint position or load; or selecting a particular graft material, as described above. For example, the shell of the graft may be a resilient material filled with a thixotropic fluid, such as silicon. During the gait cycle, the shear stress applied to the implant reduces the viscosity of the thixotropic filler, thereby allowing fluid to flow to the sides of the implant, which in turn results in reduced displacement. When the knee joint is fully deployed in the stance phase of the gait cycle, the elastic shell of the implant drives the thixotropic fluid back to its original position, and thus, the viscosity increases again, thereby increasing displacement.

An exemplary embodiment exhibiting the more complex geometry described above is shown in fig. 4, which was mentioned above in the explanation of the gait cycle. The bottom of fig. 4 shows a cross-section through a displaced portion 83 of an exemplary prosthesis, which may have a unitary configuration, such as the configuration of the prosthesis 60 of fig. 12. In other words, the displacement portion 83 in fig. 4 is seen from the head toward the tail. The support surface 86 provides a sloped surface with a smaller dorsal thickness and an increased thickness in the ventral direction. Thus, the bearing surface is configured to slide the displaced target tissue T along the bearing surface dorsally and ventrally during a gait cycle. As shown in the first diagram in fig. 4, when the leg receives a load in the stance phase, an adduction moment acts on the inner side of the knee joint. In stance phase, the joint angle is typically in the range of about 0 ° to about 20 °, with the force applied being greatest when the knee is upright or near upright. Thus, to provide optimal effect, the bearing surface 86 is configured to locate the target tissue (T) in the region of maximum displacement when the articulation angle is in the range of about 0 ° to 10 °; when the joint angle is in the range of about 10 ° to 20 °, the displacement of the region where the target tissue (T) is located is small; and minimal displacement when the joint angle exceeds about 20 deg..

The geometry of the displacement portion 83 shown in figure 4 is ideal for gait cycles when walking on a flat surface. In practice, when walking on uneven ground and walking up and down stairs, a joint angle greater than about 20 ° can subject the knee joint to a significant load, which is typically less than about 60 °, but in most cases, not greater than about 90 °. Therefore, in designing the specific geometry of the support portion, the needs of a particular patient need to be taken into account.

Fig. 14 depicts another complex geometry. In this alternative embodiment, the displacement portion 53 of the prosthesis 50 (fig. 11) is provided with a bearing surface 56 having a groove 57, or other deformation of the bearing surface geometry, to match the anatomical trajectory and motion of the target tissue as the joint moves in the gait cycle, thereby optimizing the force distribution created by the prosthesis at each joint location.

Fig. 15 depicts an exemplary implantation of a prosthesis according to the invention, in this case the implant 60 shown in fig. 12. In this example, the graft 60 is used to displace the fibular collateral ligament. A similar implant and positioning is shown as implant 10E in fig. 2. In other cases, the graft may be configured to displace other muscles or tendons, such as the biceps femoris tendon (located by graft 10B in fig. 2) or the iliotibial band. Referring again to fig. 15, the fixed portion 64 of the implant 60 is attached to the femur such that the base portion 62, including the displaced portion 63, extends caudally out of the distal end of the femur to at least partially pass through the joint space. With the spanning section 61 positioned posteriorly, the device is shaped to engage around the attachment point of the surrounding tissue (possibly including the target tissue) and to have the fixation portion 64 positioned above the femoral attachment region. Specifically, spanning section 61 avoids the attachment locations of the metatarsal and gastrocnemius lateral heads. Both the metatarsal and gastrocnemius lateral heads are attached to the posterior of the lateral femur. By offsetting the spanning section 61 posteriorly, the implant avoids these attachment locations and allows the bearing surface 66 (see fig. 12) to displace the collateral ligament laterally. The displacement portion 63 may be reshaped so as to displace the target tissue (T) trajectory at a particular location such that the contraction force of the target tissue (T) is significant in a direction perpendicular to the joint bearing surface, thereby creating little or no moment arm and torque. This helps to reduce or prevent any excessive force acting on or jogging of the device, as the excessive force or jogging loosens the fixation of the device over time.

In other exemplary embodiments of the invention shown in fig. 16-19, the prostheses of the present invention may be adapted to increase or decrease the amount of displacement applied to the target tissue during implantation or after surgery by a simple percutaneous approach. For example, the prosthesis 100 shown in fig. 16 includes a base member 102 having a movable support member 110 mounted within a displacement portion 103. The fixation portion 104 extends superiorly from the displacement portion for fixation to the femur, generally as described above. Support features 110 have outer support surfaces 106, also generally as described above. The support component 110 may be secured to the base component 102 by adjustment means such as screws 112 and alignment posts 114. Other suitable adjustment means may be employed by one of ordinary skill in the art, such as a ratchet post, a strut with a separate locking means, or other means for making the adjustment. Access holes 116 in the bearing surface 106 allow access by a specific tool to rotate the screw 112 to adjust the bearing member, and thus the amount of target tissue displacement, either inwardly (medial) or outwardly (lateral) relative to the base member. One of ordinary skill in the art will also appreciate that any of the adjustment features described herein can be incorporated with any of the geometries described above.

The prosthesis 120 in fig. 17 represents another exemplary embodiment, which includes a base member 122 having support members 130, 131 adjustably connected in a displacement portion 123. Although this exemplary embodiment includes two adjustable support members, one of ordinary skill in the art will appreciate that the displacement portion may have more sections to accommodate the adjustment capability required by the desired geometry. In this embodiment, the screw 132 again serves as an adjustment member. However, it will also be appreciated that other adjustment means may be provided.

If the support surface 126 and the individual adjustment points are curved, the prosthesis 120 comprises an expansion joint between the two support members 130, 131 to accommodate the separate bearing members according to the adjustment characteristics. While it is sufficient that two or more bearing components need only be separated to leave a small gap between them when adjusted outwardly from a minimum displacement position, it may be desirable to provide a relatively smooth, relatively abutting bearing surface 126 when adjustment and displacement are increased. As shown in fig. 17A, the interleaved fingers 137 of the expansion joint 134 help prevent the formation of large gaps that may pinch or grab the target tissue as it moves across the support surface. Alternatively, the support surfaces of the support members 130, 131 may be coated with a single membrane of suitably resilient, low friction material extending across the gap between the membranes so as to be resiliently flexible when the position of the support members is adjusted.

In a further exemplary embodiment, the prosthesis 120' in fig. 18 is substantially the same as the prosthesis 120 described above, except for the configuration of the expansion joints 134. In this exemplary embodiment, the expansion joint 134 does not have interleaved fingers, but rather utilizes bearing members 130, 131 having overlapping tapered ends 138, 139, respectively, that are slidable relative to one another to form a smooth bearing surface 126 without gaps, thereby providing a smooth overlapping expansion region.

In a further alternative embodiment, the prosthesis 140 provides an adjustment mechanism that is accessible from the anterior and/or posterior (a/P) of the knee joint, as shown in fig. 19. In this embodiment, the base member 142 has two alignment posts 154 extending from the displacement portion 143. The support member 150 receives the alignment post. One or more slidable wedge members 152 are disposed between the support member 150 and the base member 142, and between the posts 154, and are movable relative to the base member 142 and the support member 150, both rearward and forward. An actuating screw 151 or other adjustment means moves the wedge in and out below the bearing surface, which slides the bearing surface more or less outboard relative to the base member, thereby adjusting the displacement of the target tissue.

In each of the adjustable embodiments described above, the adjustment screw itself may be radiopaque and/or otherwise distinguishable from the rest of the implant under x-rays so that post-operative percutaneous adjustment of the device may be made. Alternatively, the target feature may be built into the device to locate the adjustment point without the need for the screw or adjustment member to be radiopaque itself, such as a radiopaque ring or marker built into the proximal surface of the device itself.

In still other alternative embodiments, the support member of the embodiments described herein may be moved by means of an inflatable bladder disposed between the support member and the base member. The balloon can be filled with a liquid or gas under appropriate pressure to adjust the support member position and the associated displacement of the target tissue. The balloon has an inflation portion for introducing inflation fluid by means of an inflation device, which may be similar to the inflation device used to inflate angioplasty balloons.

The devices described above generally disclose placement of the device on the femoral side of the patellofemoral joint. Devices according to embodiments of the invention may also be placed on the tibial side to displace the target tissue laterally by fixation to the tibia or fibula. An exemplary tibial fixation implant is shown in fig. 20.

Referring to fig. 20, a graft 154 is inserted under the illiotibial band (IT) just above the Gerdy's tuberosity, thereby moving the illiotibial band laterally and/or anteriorly. The graft 154 includes a displaced portion 155, a spanning section 156, and a fixed portion 157, as described above. Bone screws 159 can be passed through holes in the fixation portion to secure the implant to the tibia. Alternatively, other securing members described herein may be used. The position of the implant 154 is shown to rebalance the dynamic loads on the knee joint in the lateral and/or anterior directions. This may slow the symptoms and progression of osteoarthritis in the medial side of the knee. The strength and stability of the knee joint can also be improved by providing greater leverage to the muscles acting on the iliotibial band. It should be understood that graft 154 may also be configured to displace muscles, tendons, or tissues other than the iliotibial band, including the biceps femoris brachyces, the biceps femoris, or the fibular collateral ligament, among others.

Yet another advantage of the implant 154 positioned as shown is that it may reduce the incidence and/or severity of illiotibial band syndrome. Iliotibial band syndrome or iliotibial band friction syndrome typically occurs as a result of iliotibial band rubbing against the lateral epicondyle of the femur, or other tissue on the lateral side. Thus, embodiments of the present invention may also be used to treat conditions involving excessive friction or pressure between tissues in the knee joint or other joints, alone or in combination with osteoarthritis treatment methods. By moving the illiotibial band laterally and/or anteriorly, pressure on these tissues by the illiotibial band may be reduced.

To place the graft 154, the iliotibial band may be surgically cut from the posterior lateral edge or the anterior medial edge of the iliotibial band. But preferably from the antero-lateral edge between the tuberosity of nedy and the tuberosity of the tibia. The fixation portion 157 may then be attached to the tibia beneath the muscles that move between the two tuberosities.

It should be understood that although many of the embodiments described herein are described as being secured to only one of two bones associated with a joint, embodiments may be secured to both bones. For example, in the case of a knee joint, it may be attached to the femur and tibia or femur and fibula. In another exemplary embodiment as shown in fig. 21, the prosthesis 160 spans the entire joint and is fixed to the femur and tibia or femur and fibula, depending on the geometry. The prosthesis 160 is provided with a sliding hinge 174 or other suitable connection joint to allow the joint to move freely. Specifically, in the exemplary embodiment, base member 162 includes upper and lower stationary portions 164, with displacement portion 163 disposed therebetween and including sliding hinge 174. The displacement of the target tissue is also provided by a bearing surface 166 along which the target tissue moves. The support surface may be made adjustable by providing a separate support member and adjustment mechanism as described above. The displacement may also be controlled by additional or alternative displacement members as shown in fig. 21. In this embodiment, one or more expansion members 172 are disposed below the base member 162. The expansion member 172 may include an expansion device such as a balloon or a mechanical adjustment mechanism such as a screw mechanism. The expandable member 172 may be positioned in a particular location so as to exert force on only the femur or only the tibia or fibula, or in a more central location of the joint so as to exert force on both the femur and tibia. The sliding member constituting the displacement portion 163, or the regions where these members are connected to the upper and lower fixing portions 164, may be flexible, so that the support displacement portion 163 may be deflected to the outside as the expansion member 172 is expanded, thereby increasing the displacement of the target tissue.

In other embodiments of the invention, joint diseases involving forces in other planes, such as the lateral side, may be treated. The biodynamics of the knee joint in the coronal or frontal plane have been described above, with various embodiments that address the problem of load imbalance at the interface of the femoral and tibial articular surfaces, typically in the medial/lateral direction. When looking at the knee laterally, there are different sets of components acting anteriorly and posteriorly, creating a load between the patella and the femur.

Referring to the free body diagram in FIG. 22, the two principal moments acting around the knee are based on the ground reaction force W and the patellar tendon force F_p. The bending moment (a) on the lower leg is the result of the ground reaction force (W) and the perpendicular distance of the force from the knee joint center of motion. The equilibrium extension moment (b) is the result of quadriceps muscle forces acting through the patellar tendon and its lever arm. Thus, for a particular individual, the magnitude of the patellar tendon force F_pCan be represented by formula F_pCalculation is performed as Wa/b.

During flexion/deployment, the action of the quadriceps and patellar tendon on the patella generates Patellar Compression Force (PCF), as shown in fig. 23A. The resultant force (R) PCF depends on the magnitude of P and its effective angle of action (β).

Referring to fig. 23B, the resultant force R' is reduced by positioning implant 200 under the patellar tendon, advancing the resultant force to increase lever arm B (fig. 22), thereby reducing patellar tendon force F_pAnd the effective angle of action β' is increased, thereby reducing the horizontal component of the patellar tendon force corresponding to the PCF. Thus, the resultant force PCF (R') is reduced, thereby reducing the force with which the patella is pressed against the femur.

The expected advantages of this embodiment of the invention include a reduction in the rate of cartilage degradation and/or pain in this area. Implants, such as implant 200, can be configured to redistribute the highest load point between the patella and the femur superiorly, caudally, laterally, or medially, thereby reducing stress on any particular region of the interface. The moment arm of the muscle acting on the patellar tendon should also be increased, thereby increasing the effective strength and stability of the knee joint and reducing the overall load on the knee joint.

An exemplary embodiment is shown in fig. 24 and 25, where graft 210 is positioned on the tibia to displace the patellar tendon without cutting the tibial tubercle or cutting any of the connective tissue described above. As with other embodiments described herein, implant 210 includes a support member 212 and a bearing member 214, which in this case are integral, but may be separate components in other places described herein. The support and bearing component is functionally divided into a displacement portion 216 that engages and displaces the patellar tendon, a spanning section 218, and a fixation portion 220. Fixation portion 220 includes a means for securing an implant as described herein. In this exemplary embodiment, holes are provided in the bone screws 222 to secure the implant to the tibia.

As shown in fig. 25, implant 210 may be inserted from the outside of the patellar tendon. It can also be inserted from the inside. The graft 210 may be configured such that the fixation portion 220 is located in an area without a tendon insertion point or other connective tissue attachment point. The configuration also allows the displacement portion 216 to be positioned against the tibia at the rostral tibial tubercle and the rostral tibial capsule. Such a location transfers any load directly to the tibia beneath the graft, thereby minimizing stress on the rest of the graft and the tibia itself.

The inner surface of the fixation section 220 against the tibia, which, like the other embodiments described herein, may be designed and fabricated with suitable materials and structures to promote bone ingrowth into the implant, thereby providing more support and preventing migration of the implant relative to the bone surface to which it is fixed; in this case, the bone to which the implant is fixed is the tibia. The spanning section 218 should be designed to withstand relatively low stresses and therefore can be quite thin to avoid forming objectionable or unsightly bumps. The circular, slotted, box-shaped, curved, or other cross-sectional geometry may be selected to enhance the bending or torsional stiffness required across the section 218. Likewise, the spanning section 218 should not interfere with any muscle insertion point in the tibial tubercle region.

The displacement portion 216 is configured and sized to avoid the knee capsule and to avoid interference with the patella even when the leg is extended. The displaced portion should also minimize any additional stress on the patellar tendon itself. Thus, the bearing surface of the displaced portion 216 against which the patellar tendon rests may have a curved oblique shape, as best shown in fig. 24. The bearing surface is hard and smooth, made of a material such as polished pyrolytic carbon, steel or titanium, or coated or covered with a hydrophilic material such as PTFE. Alternatively, the bearing surface may promote adhesion and ingrowth of the patellar tendon onto this surface so that the implant will act more as the tibial tubercle extends. For example, the surface may be porous, rough, or configured with openings for bone or scar tissue to grow into to enhance adhesion.

Accurate positioning of the patellar tendon may be accomplished with implant 210, depending on the particular clinical presentation. One of ordinary skill in the art will appreciate that such implants may be used to move the patellar tendon anteriorly or laterally or antero-medially. This can be done by the following method: one side (lateral or medial) of the displacement surface is made higher than the other side and/or a track with ridges is formed on one or both sides of the bearing surface to push the patellar tendon in the lateral or medial direction.

Grafts such as graft 210 may be inserted by relatively fast therapy and are less prevalent. A relatively short cut may be made on one side of the tibial tubercle. A probe can be used from this incision to open a channel under the patellar tendon and expose the underlying tibial surface. The implant can then be inserted into this channel, mated to the tibia and attached to the femur by suitable screws or other suitable fixation elements, and the incision can then be closed. With little or no cutting of the bone, muscle or tendon, morbidity is minimal and recovery after this therapy is faster and less painful than existing surgical options.

Implants similar to implant 210 may also be applied to other anatomical locations. For example, for the anterolateral aspect of the tubercle of the mandible, the insertion site of the iliotibial band may be applied. An implant, such as implant 154 described above, may be positioned in this location. Furthermore, for some patients it is desirable to displace both the patellar tendon and the iliotibial band. This may be accomplished by two separate implants, such as implants 154 and 210 described above, or a single implant may be provided.

Figure 26 shows an example of a single implant for displacing both the patellar tendon and the iliotibial band. In this exemplary embodiment, implant 230 also includes a displacement portion 232 that is divided into two portions: an iliotibial band displacement portion 232A and a patellar tendon displacement portion 232B. The spanning section 234 formed as described above connects the displacement portion 232 to the fixed portion 236. Also, a variety of fixation members described herein may be used by those skilled in the art, with bone screws 238 being used in the exemplary embodiment. A single implant, such as implant 230, may provide greater strength and stability than if two separate implants, such as implants 154 and 210, were used.

In general, the materials, alternative configurations, and methods associated with implants 210 and 230 may be as described elsewhere herein for other exemplary embodiments.

As mentioned above, further alternative embodiments of the invention may be applied to the treatment of hip joint disease. Fig. 27 shows the basic anatomy of the hip joint H. As shown, the hip joint H is the joint between the femur F and the cavity of the pelvis P (referred to as the "acetabulum" a). The femur F extends upward from the knee joint of the body and includes a greater trochanter G located at the lateral top edge at the junction of the axis S of the femur and the femoral neck N. The lesser trochanter is located opposite the greater trochanter G and the femoral head FH is located at the distal end of the femoral neck N. The concave acetabulum a is formed at the junction of three pelvic bones: ilium I, pubis PU, and ischia IS. The surface of ligament L (omitted in fig. 27 to show detail; as shown in fig. 28) covers hip joint H, forming a pocket and helping to maintain femoral head FH in acetabulum a.

A series of muscles extend over ligament L and are connected between femur F and fibula P. These muscles include the gluteus maximus GMax (fig. 29), the gluteus medius GMed, and the gluteus minimus GMin (fig. 30). The gluteus maximus GMax is the most prominent of these three muscles. It is the largest of the gluteus muscles and one of the strongest strong muscles in the human body. Its function is to stretch the hip joints and rotate them outwards, as well as stretch the torso.

Gluteus medius GMed is a broad, thick, radial muscle located on the outer surface of the fibula P. The gluteus medius GMed begins or starts on the outer surface of the ilium I. The muscle fibers converge into a strong and flat tendon that is attached to the outside surface of the greater trochanter G.

The gluteus minimus GMin is located directly below the gluteus medius GMed. It is fan-shaped and originates from the outer surface of the ilium I. This muscle fiber ends in a tendon attached to a recess on the anterior edge of the greater trochanter G and can inflate the bladder of the hip joint H.

Gluteus medius GMed is the major muscle responsible for hip abduction, with gluteus minimus GMin playing an assisting role. Acting synergistically with these muscles are psoas, piriformis PIR (fig. 30), Tensor Fascia Latae (TFL), quadratus lumborum and rectus femoris. The main function of the hip abductor is to provide frontal plane stability to the hip during the single limb support phase of the gait cycle. This can be achieved when the frontal plane torque produced by the hip abductors is equal to the frontal plane torque produced by the body weight.

Since the moment arms of hip abductor force and body weight are different, the hip abductor must produce a force of two times body weight, and thus the compressive load on the joints during normal walking is three to four times that of body weight. For example, fig. 31 depicts the force exerted on the hip joint H. S is the center of gravity, K is the body mass, h' is the moment arm of body weight K, M is the force exerted by the abductor, h is the moment arm of abductor force M, and R is the resultant compressive force transmitted through the hip joint (R being the resultant of K and M). It can be seen that H' is much longer than H, so that the hip abduction muscle force M must be much greater than the body weight force K to achieve stability at the hip joint H.

The compressive force vector R transmitted through the hip joint H is affected by the femoral neck angle, as the angle affects the angle and moment arm of the abductor force. The angle between the longitudinal axis of the femoral neck FN and the axis S is referred to as the head-neck-shaft angle or CCD angle. This angle is typically about 150 ° for neonates, and 125 ° to 126 ° for adults ("coxa normal"; fig. 32A). An abnormally small angle is called "coxa vara" (fig. 32B) and an abnormally large angle is called "coxa valga" (fig. 32C).

In hip valgus (fig. 32C), the moment arm h' of the hip abductor is shorter than a normal hip, requiring a greater hip abductor force M. In addition, the line of action of hip abductor force M is nearly vertical, requiring more force to offset the body's moment arm h. As a result, the resultant compressive force R is greater and closer to the rim of the acetabulum a, thereby reducing the weight bearing surface of the acetabulum. This abnormal loading of the acetabulum can result in degenerative changes in the rim of the acetabulum a, causing pain and eventual loss of function in the articular cartilage.

In the case of a shallow acetabulum, the resultant force acts closer to the rim of the acetabulum a, similar to a hip valgus deformity, resulting in similar degradation of the articular surfaces of the acetabular rim. When x-ray photography is adopted, abnormal acetabulum can be determined by measuring a central edge angle, an acetabulum depth ratio, a femoral head extrusion ratio, a Lequense anteversion angle and the like.

In hip varus (fig. 32B), the line of action of the hip abductors is steeper, resulting in greater medial resultant force R, which in turn increases the probability of hip dislocation.

Fig. 33A-33B schematically depict an exemplary embodiment of the invention suitable for use in treating hip dysplasia. In the illustrated exemplary embodiment, implant 220 is installed between gluteus minimus GMin and rectus femoris RF. However, implant 220 may be mounted at any desired location between the hip capsule and at least a portion of the hip abductor muscle to achieve a desired resultant force vector M. In certain embodiments, graft 220 may be placed in tissue between the gluteus muscle and ligament L. Implant 220 is installed at the desired location and may be implanted through arthroscopic therapy, or using a small incision or incision procedure, using surgery, a balloon catheter, or another suitable therapy. As described above in connection with other embodiments, implant 220 generally includes a support portion configured to be secured through, or to, surrounding tissue; and a support portion configured to engage and displace the target tissue in a non-invasive manner. Various alternatives to the support portion and bearing portion are described herein.

Implant 220 may be constructed from a variety of materials. In certain exemplary embodiments, the material comprising implant 220 is sufficiently rigid to displace the target tissue through a smooth outer surface to minimize friction so that the target tissue does not become damaged by movement of the joint as it slides along the implant. Metals such as stainless steel or titanium, or biocompatible polymers may be used. Alternatively, graft 220 may be partially or completely constructed of a soft conformable material and may be, for example, a conformable outer membrane filled with a fluid such as water, saline, silicone, hydrogel, gas, or the like. The graft 220 may be inserted in an evacuated state and may be filled in situ after placement, or the prosthesis may be a sealing element pre-filled with a gel, fluid, polymeric or metallic beads, or other fluid, or have a pliable or flowable material.

Implant 220 may be a solid having a suitable atraumatic shape, such as a polymer or metal. Alternatively, the fixed-shape implant 220 may include a pouch having an inlet therein for the ejection and hardening of a setting material, such as bone cement. The curable material may also be a polymerizable hydrogel that is cured by radiation (e.g., ultraviolet light, visible light, thermal radiation, X-rays, etc.). The material may be cured by direct or transdermal irradiation.

The surface of implant 220 may be textured or may be smooth. The solid or conformable graft 220 may include an outer filler or lubricious outer coating or layer to assist in sliding the muscles and tendons along or over the prosthesis. Such fillers, coatings or coverings may cover a portion or all of the exterior of implant 220. For example, the padding or coating may be aligned to support or align the muscle or ligament. The implant may also have extensions covering the anterior and/or posterior regions of the hip capsule, thereby strengthening the hip capsule.

The implants may have shapes or features suitable for guiding muscles or tendons and maintaining their position on the implant. For example, the prosthesis may have grooves or channels on its outer surface for muscle and tendon extension. These muscles and/or tendons align with the grooves when the implant is installed. Alternatively, the implant may include discontinuous loops or eyelets for placement around the muscle/tendon.

Fig. 34A and 34B depict the effect of implant 220 on hip abduction muscle force M, according to one embodiment. As shown in fig. 34A, prior to installation of implant 220, hip abductor HA is extended in a first direction. The force concentration point M of the lateral edge of the acetabulum a can be seen in the figure. As shown in fig. 34B, after installation of implant 220, hip abductor HA is displaced outwardly from the joint, thereby increasing the angle and length of moment arm h of the force applied by the abductor with respect to the central axis of the joint. Thus, the resultant force R of the femoral head and body weight reaction will move further centrally into the joint and away from the lateral edge of the acetabulum a. Thus, the resultant force vector R can be more properly aligned to press the femoral head FH into full contact with the acetabulum a or otherwise provide a more appropriate force profile for the hip joint.

As for other embodiments of the invention, the prosthesis for treating hip joint disease according to the invention may comprise suitable anchors for fixing the implant in place and/or the prosthesis may be fixed by surrounding muscular and/or ligamentous structures. In one embodiment, the prosthesis extends from the pelvis P to the femur F and may be anchored on one or both sides, or no anchoring at all. Shapes, materials, or surface textures may be incorporated into the support portion to facilitate and maintain the respective placement by surrounding tissue. A tab or other feature may be provided on the implant to assist in anchoring or positioning the implant in a desired manner relative to the pelvis P and/or femur F. The femoral or pelvic side of the implant may include one or more such tabs to attach and/or position the implant in a desired manner. The graft may have a standard shape or may be customized for a particular application through the planning process described below or in an interoperative manner.

As one example, fig. 35 depicts the prosthesis 224 anchored to the femur F and pelvis P. The prosthesis 224 includes a body 223 which forms a bearing member and a support member including a fixing sheet. First sheet 225 has openings 226 to anchor prosthesis 224 to the greater trochanter and second sheet 227; on the opposite end, there is an opening 228 for anchoring to the pelvis. The body 223 may have a variety of shapes including a rectangular prism, sphere, egg, cylinder, cone, trapezoid, or other suitable shape that achieves the required force rearrangement in the joint. As described above, the prosthesis 224 may be used to alter the force vector M of the hip abductor of the hip joint.

Suture anchors, bone nails, bone screws, and other suitable connecting structures may be used to connect the trochanteric side of the prosthesis 224 through the opening 226. In a similar manner, the prosthesis may be anchored in the pelvis through the opening 228. After positioning the graft, the anchoring device may be placed percutaneously.

As described above, embodiments of the prosthesis may be installed and filled with fluid in situ. To this end, an access hole 229 may be provided to fill the prosthesis 224 during surgery, or may be mounted for use after surgery.

As another example, as shown in fig. 36, the prosthesis 230 comprises a wishbone-shaped body, wherein a main stem 240 and two legs 232, 234 for the femoral side of the prosthesis form at least part of a support member. Each of the legs 232, 234 includes a tab 233, 235 extending therefrom, each tab having an anchor opening 236, 238 therein. The fixing sheet forms at least a part of the support member. The main stem 240 is disposed against the pelvic side of the prosthesis and includes an anchoring opening 242.

For example, the two lamellae 233, 235 may be anchored on opposite sides of the large rotor G. In other alternatives, the femoral side of the prosthesis may be fixed or otherwise anchored to the femoral neck F, or a location on the femur F that is below the greater trochanter G. The main stem 240 may be secured to the ilium I, the ischial IS, or another suitable location on the pelvis P, either on the posterior or anterior side. As an alternative to the arrangement in fig. 36, the prosthesis 230 may be provided with two lamellae on the pelvic side. For example, one of the two sheets may be anchored to the posterior of the pelvis and the other to the anterior of the pelvis.

Fig. 37 depicts another embodiment of a prosthesis 244. Similar to the prosthesis 230, the prosthesis 244 includes two legs 246, 248 on the femoral side of the prosthesis, and a main stem 250 that aligns with the pelvic side of the hip joint when the prosthesis is installed. Unlike prosthesis 230, however, prosthesis 244 does not include various structures, such as tabs and/or anchoring holes, for anchoring the prosthesis to the femur. As described above, such prostheses 244 may be secured in place by surrounding muscular structures that are tightly layered around the hip capsule. Similarly, main stem 250 does not include a flap and/or anchor to connect to the pelvis.

If desired, the prosthesis may instead be anchored only on the femoral or pelvic side, and/or may include legs on either side that are anchored or held by muscle structures. As one example, legs 246 or 248 may be provided with a single anchor on one or both sides, such as a tab and/or opening, and/or stem 250 may be provided with an anchor. Any combination of anchors or muscle fixation supports may be used. In such embodiments, the bearing and support member may be integrally formed.

According to another exemplary embodiment, the prosthesis may have various thicknesses, thereby enabling various displacements of the abductor muscle and/or hip joint tissue. As an example, as shown in FIG. 37, the prosthesis 244 includes three regions having different thicknesses, i.e., X, Y and Z. Thickness X corresponds to leg 246, thickness Y corresponds to leg 248, and thickness Z corresponds to stem 250. The legs or stem, or both ends of the legs or stem, may also have different thicknesses. These regions of different thicknesses X, Y and Z may be used to facilitate fitting of the prosthesis 244 in the hip joint H and/or to provide the required force cancellation. The prosthesis 244 may be pre-shaped to have different thicknesses prior to implantation, or portions of the prosthesis may be individually expanded in situ to a desired thickness, for example, by filling with a desired amount of inflation medium to achieve the desired thickness.

Fig. 38 depicts an example of a front view of a prosthesis 260 installed in a hip joint H according to one embodiment. Fig. 39 shows the prosthesis 260 in place with ligament L and abductor muscles omitted to show detail. In the embodiment shown in fig. 38, the prosthesis 260 includes a pelvic wafer 262 and a femoral wafer 264, forming at least a portion of a support member; and both of these tabs extend from a central rounded and raised body section 265, forming a support member. The ridged configuration of the body section 265 aids in the desired displacement of the abductor muscle. The pelvic and femoral lamellae 262, 264 can be constructed of a thin and highly pliable material to minimize any impact on the articulation. For example, the pelvic flap 262 is anchored to the pelvis by a pin 266, bone screw, suture, or other suitable anchor secured to the ilium 1. The sheet may be provided with openings for the anchoring function. The femoral lamella 264 is anchored to the greater trochanter G, femoral neck, or other suitable location by a suitable anchor, such as a pin 268. The main section 265 in the embodiment shown in fig. 38 is centrally mounted and arranged so as to place the main section 265 between the ligamentum capsulatum L and the muscular structure of the gluteus minimus GMin and gluteus medius GMed when the prosthesis 260 is mounted. However, the primary section 265 may be placed closer to the pelvic attachment point (attachment) or the femoral attachment point, and may be placed elsewhere, thereby changing the force vector M as desired.

According to additional embodiments shown in fig. 40 to 42, the implant may be connected to the femoral neck N only by a support component and/or may extend laterally to the femoral neck. In this way, the prosthesis may provide a support means for displacing a significant amount of muscle and/or tissue around the femoral neck N and/or may be more easily maintained in position due to the direct connection around at least a portion of the femoral neck N. Such prostheses may be dog bone or kidney shaped, placing one side around the ligamentum bursae L or the femoral neck N. Typically, a dog bone shape includes a narrow and generally elongated central section with a hump or rounded larger diameter shape at each end. Kidney-shaped, on the other hand, approximates a bean-shape, wherein the two outer ends extend in one direction, thus forming a groove or notch on one side of the shape. For both shapes, grooves or other shapes may be provided on the other side for the tendons and muscles to slide through without slipping out of the prosthesis. A deformable pillow-like structure filled with gel, foam or beads may also be used to fit or partially wrap around the ligamentum capsulatum L or the femoral neck N.

As one example, as shown in fig. 40, the dog bone shaped prosthesis 270 extends laterally to and is positioned around the femoral neck N and/or ligament L. The dog bone prosthesis 270 in fig. 40 comprises a narrow central section 271 between two raised outer rounded ends 273. The narrow section is long enough so the two ends are disposed on opposite sides of ligament L or femoral neck N. In the embodiment shown in fig. 40, the prosthesis is connected into the femoral neck N via a central section 271 by two anchors, e.g. pins or screws 272, 274. However, as in the previous embodiments, the prosthesis may be installed without fasteners, or the prosthesis may be otherwise anchored or anchored in other locations. The upper portion of the prosthesis 270 may guide the muscles through an upper sliding seat (saddle) formed between the two ends 273 and along the central section 271 of the dog bone shaped prosthesis 270.

Fig. 41 depicts another embodiment of a prosthesis 280 that extends laterally to the femoral neck. Prosthesis 280 is kidney-shaped and includes a more narrow central section 283 and two rounded outer ends 284. A notch 285 is formed between the two ends. In one embodiment, the prosthesis is shaped such that the recess conforms to the curvature of the femoral neck and/or ligament L to which the prosthesis is connected, thereby allowing the prosthesis to be at least partially positioned around the femoral neck N when installed. In the embodiment shown in the figures, an optional pin or screw 282 may be used to anchor the prosthesis 280 to the femoral neck N, although other anchors may be used, or no anchor may be used.

As another alternative, the prosthesis may be anchored to the femoral neck using a U-or C-shaped bracket or strap or other structure extending around the femoral neck. As an example, the prosthesis 290 shown in figure 42 is mounted on a U-shaped bracket 292 that extends around the femoral neck N and/or ligament L. The U-shaped bracket 292 is curved to fit closely around the femoral neck N and includes bolts 293 that extend through openings (not shown) at both ends of the bracket and along opposite sides of the femoral neck. Bolts 293 may be used to lock the U-shaped bracket 292 in place. Prosthesis 290 in fig. 42 is spherical, but alternatively, U-shaped bracket 292 may be used with other shaped prostheses, such as dog bone shaped prosthesis 270, or kidney shaped prosthesis 280.

According to a further embodiment, the prosthesis may be mounted as a cap on the greater trochanter G for displacing the hip abductor. As an example, the prosthesis 296 shown in FIG. 43 is mounted as a cover on the large rotor G. The prosthesis 296 includes a horizontally extending portion 298 and a vertically extending portion 2100, thereby forming an upside down L-shape with respect to the greater trochanter G. In the embodiment shown in fig. 43, the prosthesis 296 is anchored by pins 2102, 2104, but may be anchored or connected in other ways, including U-shaped or C-shaped brackets or straps, or other structures extending around the femoral neck, as described above. As shown in fig. 43, the outer side of the prosthesis 296 is rounded and protrudes from the outer side of the hip joint, thereby substantially displacing the hip abductor HA. In this exemplary embodiment, the bearing and support members are combined in the same manner as described above for implant 40.

To assist the hip abductor muscles HA and/or tendons or other tissue to slide over the prosthesis 296 or another cap-like prosthesis, the outer surface of the cap may be smooth. Alternatively, guides or other structures may be provided to maintain the tendons and muscles in position and provide a sliding feature. As an example, as shown in FIG. 44, the prosthesis 2110 is similar in shape to the prosthesis 296, including a recess or channel 2112 for slidably receiving and guiding the hip abductor muscle HA as the prosthesis 2110 moves with the femur. Other structures, such as rings, eyelets, tubes or other features may be used to guide and position the hip abductor HA and/or ligaments and tendons.

As another example, a prosthesis, such as prosthesis 2120 shown in fig. 45, may include one or more external rollers 2122 for allowing hip abductor HA to roll prosthesis 2120 as femur F moves. Prosthesis 2120 includes a series of three rollers 2122 that are rotatably mounted to the outside and/or over prosthesis 2120 so as to be aligned with hip abductor HA and its main direction of movement.

According to another embodiment, the prosthesis may be configured to expand in situ, such that the prosthesis may be inserted in a contracted state through a cannula or small incision procedure, expanded in situ, and installed in an expanded state. As one example, the device may include one or more hinges, or may be bendable to retract into a smaller space and expand upon installation. A spring or other device may be used to expand the prosthesis, or the device may be expanded mechanically or otherwise. The prosthesis 2130 in the example shown in fig. 46-49 includes two legs 2132, 2134 connected by a hinge 2136. The two legs 2132, 2134 form a cap which can be mounted as a support component on the greater trochanter G or the femoral neck N, for example.

A conveyor 2138 may be provided to capture the hinge 2136 during insertion, hold the legs 2132, 2134 together, and open the legs during installation. The delivery device 2138 includes a hollow shaft 2135 configured to receive the hinge 2136 and legs 2132, 2134 within the shaft during delivery. The walls of the delivery device 2138 serve to capture the legs 2132, 2134 during insertion and to hold the legs closed. The prosthesis 2130 is held in the shaft by friction with the inner wall of the shaft, or alternatively, an inner shaft (not shown) may be selectively slidably positioned within the shaft 2135, wherein the shaft 2135 has a distal coupling mechanism adapted to releasably grasp the hinge 2136.

After insertion of the prosthesis 2130 via the delivery device 2138, the delivery device may be retracted to expand the prosthesis, or the prosthesis may be expanded mechanically or otherwise. As one example, an inner shaft (not shown) can be releasably coupled to the prosthesis 2130, and movement of the inner shaft will cause the legs 2132, 2134 to open and the prosthesis to be released from the delivery device. For example, during installation, the legs 2132, 2134 can be separated to wrap around the femoral neck N (fig. 47) and/or ligament L, or greater trochanter G. For example, in one installation embodiment, the prosthesis 2130 can be expanded around the femoral neck N (fig. 48) and can be moved thereover and then installed onto the greater trochanter G.

Because of the ability to be installed when closed, minimally invasive surgery can be achieved using the prosthesis 2130. Thus, a small incision may be used, and/or the prosthesis may be installed through the cannula. After installation, the device may be anchored in place by pins or other suitable fasteners, or may be held in place by the muscles or tissue structures surrounding the femur F.

The prosthesis 2130 may be configured to expand outwardly to form a cap that fits over the greater trochanter G as shown in fig. 48, or fits around a portion of the femoral neck N in a suitable manner as shown in fig. 49. As another example, the prosthesis may include two or more elements, such as hinged or folded elements, that are connected together to form a contiguous graft. As one example, two or more hinged or folded elements may be introduced into a space and then locked together to form a contiguous implant. Multiple elements may be locked together by aligning features, the elements may be locked together by snap-locking, or the elements may be connected by fasteners, crimping, or another suitable means. As an alternative, when multiple elements are placed in position, the elements may be placed together and may abut one another via suitable fasteners, such as bone screws, bone nails, pins, or other fasteners. In one embodiment, each element or portion is expanded in situ.

Fig. 50 depicts one example of such a prosthesis 2140, in which the first hinge element 2142 is butterfly shaped, with first and second crescent, wishbone, or triangular legs 2144, 2146 connected via a hinge 2148. The two crescent-shaped legs 2144, 2146 are arranged so that the recessed portion of each leg is outward and facing each other. The second hinge element 2150 also comprises two similar crescent-shaped legs 2152, 2154 connected via a hinge 2156. The two articulating members 2142, 2150 may be attached to each other prior to implantation, or may be separately introduced and attached in situ. The two hinge elements 2142, 2150 can be mounted by: for example, the first hinge member 2142 is first installed, and then the hinge member 2150 is installed on top of the first hinge member 2142 and disposed around the first hinge member 2142. In each case, the hinge elements are folded before and during installation and then expanded in situ. The hinge elements 2142, 2150 may be anchored to a location in the prosthesis 2140 in a suitable manner, for example, at an anchor location 2160. One such anchoring location may be at the overlap of the two hinges 2148, 2156. As shown in fig. 51, for example, the prosthesis 2140 may be installed on the greater trochanter G or another suitable location.

According to another embodiment, a strap, strap or other tensioning mechanism may extend around and tighten on the femoral neck N and the hip abductor muscles HA and/or the hip capsular ligament/tendon. The strap or other structure may be tightened to increase the tension, thereby increasing the tension of the femur F. This method can be used, for example, when an increase in tension is able to produce a resultant force that is tailored to the particular pathology of the patient. For example, if the patient is experiencing excessive loads on the inside of the joint, a strap may be used to increase the tension on the outside of the joint, thereby increasing the lateral force component and reducing the load on the inside of the joint. In such embodiments, the strap or band extends around the femoral neck and hip abductor and/or capsular ligament/tendon on the outside of the joint, but extends under the hip abductor/tendon on the inside of the joint. The strap or strap arrangement may be reversed if the patient experiences excessive loads on the outside of the joint.

As with the previous embodiments, the strap or band may have a smooth inner surface to allow the muscle to slide relative to the strap or band. The strap or band may optionally extend around only the femoral neck portion and may be a rigid half ring (partialing) or ring. The strap or strap may optionally be secured to the femoral neck via one or more anchors, such as pins or screws. The straps or bands may be flexible or may be rigid rings or rings constructed of fabric, metal or polymer. The rigid structure may be circular, oval, racetrack, or another suitable shape, and may be discontinuous so as to be insertable around the muscles and femoral neck N. The straps or bands may be elastic to act as springs or may be inelastic.

Fig. 52 depicts one example of such a strap or strip, with strip 2170 extending around femoral neck N and hip abductor HA. The straps or bands may take many forms and may be arranged accordingly depending on the force required. In such embodiments, the bearing members are formed to act inwardly and the support members oppose thereto and encircle the bone or other tissue in the fixed position.

If desired, a strap or strip, such as strap or strip 2170, may include an adjustment mechanism to enable increased tension in the muscle and/or tendon by tightening the strap or strip. Examples of the binding mechanism used are shown in fig. 53 to 56. In FIG. 53, a one-way clamp is provided to allow the surgeon to install the tensioning strap and pull on the free end 2182, thereby cinching the strap 2180 around the femoral neck N and the hip abductor HA. The device in FIG. 53 includes a catch band 2183 and a pawl 2184. The strip 2180 includes a plurality of openings 2186 along its length. The installer pulls on the free end 2182 of the strap, pulling upward to prevent the opening from being caught by the pawl 2184. Upon pulling, the catch strap 2183 maintains the alignment of the free ends 2182. When the strip 2180 is tightened, the installer pulls the free end 2182 downward and aligns the pawl 2184 with the desired opening 2186 in the strip. A catch band 2183 and pawl 2184 hold the free end 2182 in place.

Another example of a one-way clamp 2190 is shown in fig. 54, where a pawl 2192 engages a tooth 2194 on a strip 2196. The teeth 2194 include a sloped front side and a blunt rear side. The pawl 2192 engages the blunt rear side, preventing the teeth 2194 from retracting. The angled front side serves to angle the teeth in one direction past the pawl 2192 as the clinician pulls on the free end of the strap 2196.

Another example of a cinching mechanism is shown in fig. 55, where a device 2200 is configured as a hose clamp and includes a screw 2202 that engages an opening 2204 in a strap 2206. Rotation of screw 2202 tightens or loosens the strap depending on the direction of rotation.

Fig. 56 depicts one example of another device 2210 that may be used as a cinching mechanism. The apparatus 2210 comprises two rigid C-shaped members 2212, 2214 connected at one edge via a hinge 2216 and at the other edge via a screw 2218. The device 2210 may be tightened or loosened by rotation of the screw 2218.

Fig. 57 depicts a prosthesis 2300 similar to prosthesis 220, wherein the prosthesis is connected to hip abductor HA via a strap 2302. Band 2302 anchors prosthesis 2300 in place. The strap 2302 may be tied or clamped into place. In one embodiment, the strap uses a cinching mechanism, such as any of the cinching mechanisms described above, to cinch the strap 2302 into position around the hip abductor HA. Alternatively, a prosthesis such as prosthesis 2300 may be installed in place and a strap or band may extend around the muscle or ligamentum bursae, thereby maintaining the position of the prosthesis without the need to connect the band to the prosthesis. In this way, the straps or bands help maintain the prosthesis in place.

For example, in another embodiment of the invention shown in fig. 58-60, a graft 3100 for treating hip joint disease is shaped to fit around the insertion point of connective tissue (including target tissue) around the joint. Depending on the particular joint anatomy and patient, the implant can be used to secure the fixation portion in place while still positioning the support and displacement portions below the target tissue while minimizing trauma to vital intervening tissue. For example, as shown in fig. 58 and 60, graft 3100 may include three sections, a front section 3110, an upper section 3120, and a rear section 3130. The segments 3110 and 3130 are support members that form fixation segments, and may include features such as screw holes 3114, 3134 to accommodate bone screws 3112 for fixation to bone (as shown in fig. 58). Section 3120 includes a support member 3122 having a support surface 3124 therein as described above.

The implant 3100 may have a unitary structure or may comprise two or more interlocking units assembled together. The different sections may be constructed of the same material or different materials, for example, the support section 3120 may be made of pyrolytic carbon, while the fixation section may be made of titanium or other similar bone-compatible materials.

To treat a specific anatomy, the anterior segment 3110 can be shaped to attach to the femur by avoiding the attachment site for muscles such as Gluteus Minimus (GM), piriformis (P), and obturator internus and superior infertile muscles (O). Other sites to be avoided include the vastus lateralis muscle on the medial side, and the superior vastus intermedius and vastus medialis muscles. The posterior section 3130 may be shaped to connect to the femur between the attachment sites of the quadratus femoris and iliocostal muscles. In the sagittal plane, sections 3110 and 3130 may also be shaped as needed to avoid any muscle (non-target tissue) extending through the medial to lateral sides.

In a further alternative embodiment, instead of installing some kind of device, a fluid may be injected into the space required in or near the abductor of the hip joint hardened to a solid, thereby allowing the fluid to harden to a solid which will provide the function of the prosthesis. As an example, the prosthesis may be injected as a liquefied polymer or foam material into the space between the gluteus muscles and the femoral neck and hardened. The material may have adhesive properties to adhere to the ligamentum bursae around the femoral neck. A balloon or other inflatable member or retractor can be inserted to create a space between the femoral neck and gluteus muscles for injecting material.

In another aspect of the invention, the corresponding principles and teachings can be applied to joints of animals in a veterinary setting. One exemplary embodiment of such a veterinary application is a canine hip joint. Referring to the hind limbs, fig. 61A and 61B depict the general arrangement of the bones associated with a canine hip joint. As shown in figure 62, the male pallet study showed that the maximum vertical force exerted by the hind legs on the ground during the stance phase of the gait cycle varied between 24% and 41% of the total body weight. The dogs were subjected to more load on their forelegs, between 53% and 65% of their body weight. In the stance phase of the gait cycle, the orientation of the femur relative to the pelvis is shown in fig. 63.

In canine hip dysplasia, it is particularly important that the forces acting on the frontal plane (abduction/adduction) are in three leg stance (i.e. one raised lower limb) during the gait cycle. Figure 64 depicts a two-dimensional biomechanical model of a canine hip joint, wherein I represents the ilium; s represents the sacrum; h represents femoral head; f₀Representing a gravity-based force; m₀Representing the moment caused by the axial muscle; f_aRepresents the abducted muscle force; f_hRepresenting hip joint reaction force; theta_aRepresents F_aAngle of application of force; theta_hRepresents F_hAngle of application of force.

In the three-legged model, external forces acting on the canine skeleton must be offset by internal forces in order to achieve equilibrium. The external force includes a force F exerted by the gravity of the torso and head₀And a torque (torque) M exerted by the torsion of the axial muscle₀. The canine hip joint is subjected to greater loads than body weight because it is also subjected to additional abducting muscle forces and pelvic torque. Hip joint force F_hAnd abducted muscle strength F_aDirectly affected by the femoral neck angle and the abduction/adduction angle of the bearing lower limb. A larger femoral neck angle reduces the distance between the femoral head and the greater trochanter, thus requiring more abducting muscle force to overcome the shortened lever arm. This increase in muscle strength will result in an increase in hip joint force. Furthermore, abductor angle θ_aThe greater the hip joint force angle theta_hThe larger. Theta_hThis increase in load will result in increased loading of the rim of the acetabulum, which will result in degradation of the acetabular cartilage and, in turn, hip osteoarthritis. A reduction in the femoral neck angle will cause the lever arm distance to increase, thereby simultaneously reducing the abductor muscle force F_aResultant force of hip joint F_h。

When the acetabulum coverage of the femoral head is insufficient and the hip joint resultant force F_hAct onAdding to the location near the rim of the acetabulum may also result in overloading the rim of the acetabulum. This occurs when the acetabulum is not fully ventrally tilted.

Surgical procedures for treating hip dysplasia include: femoral intertrochanteric osteotomy (ITO), thereby reducing femoral neck angle and hence hip forces; or three pelvic incisions (TPO), thereby increasing the ventral inclination of the acetabulum (ventrovision). A study that analyzed hip joint forces after TPO concluded that the most significant effect was obtained when increasing the ventral inclination from 0 to 20 degrees and the limited effect was obtained when increasing the ventral inclination from 30 to 40 degrees. The study also concluded that the beneficial clinical effects of TPO were achieved by reducing the amount of force acting on the hip joint while simultaneously extending the coverage of the femoral head.

In an exemplary embodiment of the invention, as shown in fig. 65, a graft 4100 is placed on the femur under a hip joint muscle group (e.g., gluteus medius, gluteus profundus, etc.). In this way, a change in force vector can be achieved, similar to the biomechanical changes achieved by osteotomy, but without the need for such invasive surgery. Implants such as implant 4100 are suitable for dogs with large femoral neck angles and inadequate ventral inclination of the acetabulum.

While the graft 4100 may be placed around the greater trochanter region, one of ordinary skill in the art will appreciate that the graft may be placed in other regions (e.g., the femoral neck) to provide for proper displacement of the abductor muscle. As shown in fig. 66, displacement of the abductor will alter the line of action of the abductor. This displacement will increase the lever arm of the abductor muscle, thereby reducing the abductor muscle force necessary to achieve mechanical equilibrium during the gait cycle, thereby reducing the resultant hip joint force. Furthermore, abductor angle θ_aWill result in a hip joint resultant force angle theta_hChanging more towards the inside. This change in direction of hip joint fusion reduces the load on the acetabular rim and may improve the stability of the joint.

As with other embodiments described herein, graft 4100 is designed not to interfere with any muscle insertion point in the greater trochanter region. And as described elsewhere herein in connection with exemplary embodiments of the invention, the graft 4100 can be attached to the underlying bone using anchors, screws, wires, or other fixation members. The prosthesis may comprise a plurality of components, for example, the prosthesis may comprise: an anterior component connected to an anterior region of a femur; a posterior component coupled to a posterior region of the femur; and a third component connected to the other two components and displacing the abductor muscle.

The graft 4100 may also be implanted by arthroscopic therapy, or using a small incision or incision approach. The thickness of the implant can be adjusted during surgery, or at any time after surgery. This may be achieved by mechanical means. The bearing surface of the implant may be textured or may be smooth. The surface in contact with the bone may be textured or porous to allow bone ingrowth; while the surface in contact with the soft tissue may be smooth to facilitate movement of the associated tissue.

An exemplary treatment regimen according to one embodiment of the present invention is shown in fig. 67. For illustrative purposes, this example is described in the context of hip joint treatment, but it will be appreciated by those of ordinary skill in the art that the process may be equally applicable to other locations described herein. Beginning at 1000, a plan is made for installing a prosthesis, such as prosthesis 220. At 1002, a prosthesis is installed, for example, by the procedure described above.

Plan 1000 may involve any number of different therapies. Part of the plan 1000 may involve an assessment of the hip joint by a particular physician according to known therapies, and based on certain assessment results, the selection and installation of a particular prosthesis. For example, a prosthesis may be selected from many of the embodiments described above, or a combination of prostheses may be selected.

As another example of the plan 1000, a computer model of the hip joint H may be generated, thereby enabling the physician to determine where to install the prosthesis, and/or which type of prosthesis should be installed, based on a visual model of the hip joint. In one embodiment, preoperative images (X-ray, MRI, etc.) may be used to determine the size of the graft and the optimal location of the graft. In the analysis, information such as a center rim angle, an acetabular depth ratio, a femoral head compression ratio, a Lequesse anteversion angle, a CCD angle and the like can be used. The size of the implant may be selected from a set of standard sizes, or the implant may be shaped during surgery, or a customized implant may be used to meet the needs of a particular patient.

As another example of a plan 1000, a given prosthesis may be a default prosthesis for a particular abnormal structure or symptom of a hip joint, or may be used for a particular abnormal condition. For example, in one embodiment, the implant 220 is suitable for patients with shallow acetabulum A, or with hip valgus. Other prostheses described herein are more suitable for use in other hip abnormalities. Knee, shoulder, ankle and elbow joint pathologies can be treated using the same plan.

The following paragraphs will describe further alternative exemplary embodiments of the present invention.

In one example, an apparatus for treating a joint is provided, wherein the joint comprises at least first and second bones having opposing articular surfaces, and the bones are subjected to forces exerted by a target tissue surrounding the joint; the device includes a support portion adapted to be secured to tissue or bone, and a bearing portion supported by the support portion. The support portion is configured and dimensioned for placement proximate the target tissue. The bearing portion has at least one bearing surface configured to displace the target tissue relative to the joint a sufficient distance to redirect forces applied by the target tissue to the hip joint for therapeutic purposes. Such exemplary devices may also include one or more of the following features:

at least one bearing surface adapted to engage the target tissue in a non-invasive manner.

A support portion located below the bearing portion and including a support surface opposite the bearing surface adapted to contact underlying tissue.

A connecting member for securing the support portion to underlying tissue.

Is made of or comprises a soft compliant material.

Is constructed of, or includes, a rigid material.

A support surface adapted to contact at least one of the first and second bones.

A connecting member for connecting the support portion to a bone.

Fixation means for fixing the graft to soft tissue may be configured to fix the graft to the target tissue.

The support portion includes a support member and the bearing portion includes a bearing member.

The bearing member is a separate member from the support member.

The support member and the bearing member form a single unitary structure.

The bearing member is adjustable relative to the support member to control displacement of the bearing surface from the support surface.

An adjustment mechanism cooperating between the bearing member and the support member.

The adjustment mechanism includes a screw adjustment.

The adjustment mechanism is configured to adjust after the support surface is secured to the respective tissue or bone.

The adjustment mechanism includes a wedge adjustment.

The support member is a different material than the support member.

The support member is a soft compliant material.

The support member is made of a material including silicone, titanium, stainless steel, or pyrolytic carbon.

The support member is configured to provide different amounts of displacement of the target tissue in response to the joint flexion angle.

The support member is ramp shaped.

The ramp shape is configured and dimensioned to allow the target tissue to move along the ramp to different degrees of displacement as the joint moves through different bending angles.

The support member has a recess for receiving and guiding the target tissue.

The implant is configured to displace the target tissue in a first direction generally orthogonal to the support surface and in a second direction generally parallel to the support surface.

The bearing surface is a low friction material.

The support member has a fixed portion and a displacement portion, wherein the bearing member is disposed in the displacement portion.

The fixation portion includes a member for assisting fixation to the bone.

The displacement portion is configured and sized to be received around a portion of the greater trochanter or femoral neck; and the fixation portion includes a first portion configured and dimensioned to extend anteriorly from the support portion between a piriformis attachment point (attachment) and a gluteus minimus attachment point and posteriorly between a quadratus femoris attachment point and a iliocostalis attachment point.

The fixation portion configured and sized to be received around a portion of the femoral neck; and the displacement portion is configured to extend around at least a portion of the hip abductor muscle to displace the muscle toward the femoral neck.

The support member further includes a spanning section between the fixed portion and the displacement portion.

The spanning section is configured and sized to avoid selected anatomical features between the fixed position and the target tissue displacement position.

The fixation portion configured and dimensioned to be head-fixed against the femur relative to the lateral head of the gastrocnemius muscle; the spanning section being configured and sized to extend posteriorly around the lateral head of the gastrocnemius muscle; and the support portion is configured and dimensioned to extend caudally relative to the lateral condyle and underlie at least one of the lateral fibular ligament and the biceps femoris tendon.

The fixation portion is configured and sized to be secured against the tibia adjacent to the standyland and the soft tissue to be displaced is the iliotibial band; the displacement portion configured and sized to extend cephaladly from the tibia to a position proximal to the iliotibial band; and the spanning section is configured and sized to extend outwardly from the fixed portion to the displaced portion.

The fixation portion is configured and dimensioned to be secured against the tibial tuberosity; the spanning section is configured and sized to extend from the fixation portion toward the head portion; and the displaced portion is configured and sized to extend medially from across the segment and over a central portion of the tibial condyle proximate the patellar tendon.

In another exemplary embodiment of the invention, an apparatus is provided for treating a joint to redistribute forces in the joint, the joint comprising at least first and second bones having opposing articular surfaces, the bones being positioned relative to each other by associated muscle and connective tissue, the tissue comprising a target tissue to be treated; the apparatus comprises: a support member configured and dimensioned to be positioned in a treatment position beneath at least one target tissue, the support member having a thickness sufficient to displace the target tissue from a natural path to a treatment path when positioned in the treatment position; and a support surface disposed on the support member, the support surface configured to engage the target tissue in a non-invasive manner and to move the target tissue along the surface. Such exemplary devices may also include one or more of the following features:

the bearing component is sized to displace the target tissue by an amount and direction sufficient to reduce loading on at least a portion of the articular surface.

A connecting member for fixing at the treatment site by connecting the support member to the surrounding tissue.

A support member for supporting the bearing member.

The bearing member is a separate member from the support member.

The bearing member is adjustable relative to the support member to selectively control displacement of the target tissue.

An adjustment mechanism cooperating between the bearing member and the support member.

The support member is a soft compliant material.

The support member is configured to effect different amounts of displacement of the target tissue in response to the joint flexion angle.

The support member is ramp shaped.

The support member has a fixed portion and a displacement portion, wherein the bearing member is disposed in the displacement portion.

The support member further includes a spanning section between the fixed portion and the displacement portion.

The spanning section is configured and sized to avoid selected anatomical features between the fixation portion and the target tissue displacement location.

A support surface is disposed on the support member opposite the bearing member, the support surface being configured and dimensioned to support the bearing member against tissue underlying the target tissue.

The support surface is adapted to contact another target tissue.

The support surface is adapted to contact at least one of the first and second bones to support the same.

In a further exemplary embodiment of the present invention, there is provided an apparatus for treating a disease of a joint, the joint being subject to a force exerted by soft tissue in the vicinity of the joint; the device includes a prosthesis implantable in a position to engage soft tissue to displace the soft tissue sufficiently to change the position, angle or magnitude of a force applied by the soft tissue for therapeutic purposes to the joint. Such exemplary devices may also include one or more of the following features:

the joint is a hip joint and the prosthesis is configured and sized to overcome forces that cause dysplasia of the joint, wherein the hip joint is a human hip joint or a canine hip joint.

The joint is a knee joint and the prosthesis is configured and sized to overcome forces that cause osteoarthritis and/or to overcome forces that cause excessive patellar compression.

The prosthesis includes an anchoring member for anchoring the prosthesis in a fixed position relative to at least a portion of the joint.

The prosthesis displaces the soft tissue in a first direction away from the base tissue and outwardly relative to the base tissue in a second direction.

The joint is surrounded by a joint capsule, and wherein the anchoring member is configured to secure soft tissue or bone outside of the joint capsule.

The prosthesis is a hard material.

The prosthesis comprises a soft outer layer forming a chamber and wherein the chamber is filled with a fluid or gel.

The prosthesis comprises a nozzle for filling the chamber with a fluid or gel after implantation of the prosthesis.

The prosthesis is bifurcated so as to form a wishbone shape, a Y shape or a V shape.

The prosthesis is configured to be mounted on the greater trochanter or the femoral neck.

The prosthesis is configured to be mounted on the lateral femoral condyle.

The prosthesis is configured to be mounted to at least one of: femur, pelvis, fibula, tibia, radius, ulna, scapula, calcaneus, humerus, vertebra, tarsal, metatarsal, carpal, metatarsal, or talus.

The prosthesis is configured to be mounted to the tibia adjacent to the nodus of didymitis, and the soft tissue to be displaced is the illiotibial band.

The prosthesis is configured to be mounted to the tibial tuberosity and the soft tissue to be displaced is the patellar tendon.

In yet another exemplary embodiment of the present invention, a method of treating a joint to achieve force distribution in the joint is provided, the joint including at least first and second bones having opposing articular surfaces, the bones being positioned relative to one another by associated muscle and connective tissue; the method comprises the following steps: selecting at least one of the associated muscle and connective tissue as a target tissue to be treated; displacing the target tissue in a manner that does not sever the bone or the target tissue; and redistributing the load in the joint to achieve therapeutic goals through displacement. Such exemplary methods may also include one or more of the following features or steps:

the displacement is in a direction away from the joint.

The displacing includes placing the graft under the target tissue.

The implant includes a biocompatible component having a thickness corresponding to the selected tissue displacement.

The placing includes inserting the graft into a therapeutically effective position beneath the target tissue and securing the graft in the therapeutically effective position without substantially restricting movement of the target tissue.

The joint is a knee joint, and the target tissue is positioned and displaced laterally relative to the knee joint.

The securing includes attaching the graft to the target tissue.

The fixation includes attaching the graft to soft tissue underlying the target tissue.

The fixation includes attaching the prosthesis to bone underlying the target tissue.

The fixation includes attaching the prosthesis to the supporting tissue by sutures, screws, staples, adhesives, or bands.

The supporting tissue is at least one of: target tissue, soft tissue below the target tissue, bone below the target tissue.

The natural force exerted by the target tissue acts on the joint via the effective moment arm, and by displacing the target tissue, the target tissue will move to a position where the effective moment arm is increased.

The effective moment arm increases by about 10 mm to about 30 mm.

The increase in effective moment arm is sufficient to increase the torque by about 20% to about 30%.

The target tissue is the illiotibial band.

The target tissue is the lateral quadriceps-patellar tendon.

The target tissue is the biceps femoris muscle.

The target tissue is biceps femoris tendon.

The target tissue is the popliteal muscle.

The target tissue is the lateral gastrocnemius muscle.

The target tissue is one or more abductor muscles.

The joint is a hip joint and the target tissue is at least one abductor muscle, which may include one or more of gluteus minimus, gluteus medius, and/or gluteus maximus.

The joint is a knee joint and the target tissue is displaced anteriorly, the target tissue being one or both of a patellar tendon and/or an iliotibial band.

The displacement of the target tissue is changed in response to the joint flexion angle.

In a further exemplary embodiment of the present invention, a method of treating a joint is provided, the joint including at least first and second bones having opposing articular surfaces, the bones being subjected to forces exerted by target tissue surrounding the joint; the method includes implanting a prosthesis to displace a target tissue relative to the joint, wherein a force applied by the target tissue will change direction to redistribute a load on at least one articular surface without cutting the first or second bone. Such exemplary methods may also include one or more of the following features or steps:

displacing the target tissue laterally, anteriorly, or posteriorly relative to the joint.

The prosthesis is implanted on the same side of the joint as the target tissue.

After the prosthesis is implanted, the size of the displacement of the target tissue is adjusted.

The joint is a knee joint and the prosthesis is implanted on a first side of the knee joint to reduce loading on the articular surfaces on a second side of the knee joint. The first side may be an outer side and the second side may be an inner side.

The joint is a knee joint and the prosthesis is implanted on the tibia to reduce the load on the femur.

The joint is a hip joint and the prosthesis is implanted on a first side of the hip joint to move a resultant force in the joint away from the first side. The first side may be an outer side. The hip joint may be a human hip joint or a canine hip joint.

The force exerted by the target tissue acts via the moment arm prior to displacing the target tissue; and displacing the target tissue to substantially increase the moment arm.

The force exerted by the target tissue causes the joint to open to the side opposite the target tissue.

In another exemplary embodiment of the present invention, a method of treating a joint is provided, the joint including at least first and second bones having opposing articular surfaces, the bones being subjected to forces exerted by target tissue surrounding the joint; the method comprises the following steps: creating a surgical opening to access a target tissue; displacing the target tissue relative to the joint to a displaced configuration to redirect a force exerted by the target tissue on the joint without cutting the first or second bone; and closing the surgical opening, wherein the target tissue is held in a displaced configuration. The displacing may comprise positioning the prosthesis under the target tissue.

In a further exemplary embodiment of the present invention, a method of treating a hip joint having a hip abductor acting thereon; the method comprises the following steps: the prosthesis is mounted in a position to engage at least a portion of the hip abductor or connective tissue connected thereto to alter the force vector applied by the hip abductor to the hip joint. Such exemplary methods may also include one or more of the following features or steps:

the prosthesis is installed without cutting the bone associated with the hip joint.

The hip joint has a hip capsule and a prosthesis is mounted on a surface of the hip capsule.

The prosthesis displaces the hip abductor muscles to alter the force vector.

The hip abductor is displaced laterally.

The hip abductor muscles are displaced anteriorly or posteriorly.

The prosthesis changes the angle of the force vector relative to the hip joint.

Installation involves installing the prosthesis between the gluteus muscles surrounding the hip joint and the ligamentum capsulatum.

Installation involves inserting the prosthesis in an evacuated state and then filling the prosthesis with a fluid.

Installation involves inserting a bladder having an inlet, then filling the bladder with a curing material, and allowing the curing material to harden.

The prosthesis includes a feature for guiding at least one of the muscle and tendon, and wherein installing includes aligning one of the muscle and tendon with the feature.

The prosthesis is anchored to the pelvis and/or femur of the patient.

The prosthesis is anchored to the femoral neck of the patient.

Installation includes installing the prosthesis in a transverse femoral neck.

Installation includes installing the prosthesis in a manner that encircles the patient's femoral neck.

Installation involves inserting the prosthesis in a contracted state and then expanding the prosthesis in situ to an expanded state.

Installation includes inserting the prosthesis in a contracted state, installing the prosthesis in the contracted state, and expanding the prosthesis in situ to an expanded state.

Installation includes assembling two or more portions to form the prosthesis, wherein each portion expands in situ.

Installation involves injecting a fluid into the hip joint, thereby allowing the fluid to harden into a prosthesis.

Installation includes attaching the prosthesis to soft tissue proximate the hip joint.

The prosthesis is attached to at least a portion of the hip abductor or connective tissue attached thereto.

The mounting includes extending a strap or band around at least a portion of the hip abductor muscle and tightening the strap or band around at least a portion of the hip abductor muscle to vary the force vector applied by the hip abductor muscle.

The strap or strap pulls at least a portion of the hip abductor muscle towards the femoral neck.

Treating the hip joint comprises treating the hip joint of a human or non-human animal.

The shape and position of the prosthesis is prepared with computer-aided planning.

The prosthesis shape is prepared during the surgical procedure.

In a further exemplary embodiment of the present invention, a method of treating a hip joint having a hip abductor acting thereon; the method includes installing the prosthesis in a position to engage the greater trochanter of the hip joint to alter a force vector applied by the hip abductor to the hip joint. Such exemplary methods may also include one or more of the following features or steps:

the prosthesis is mounted on the greater trochanter of the patient to form a cover over the greater trochanter.

Installation involves inserting the prosthesis in a contracted state and expanding the prosthesis in situ to an expanded state.

Installation includes assembling two or more portions to form the prosthesis, where each portion may have a pair of movable legs that can fold upon introduction and can expand upon installation.

Installation involves placing the prosthesis in a collapsed form in a delivery device and then releasing the prosthesis in an expanded form from the delivery device.

Installation includes connecting a pair of hinged legs of the prosthesis from a collapsed configuration to an expanded configuration.

In another exemplary embodiment of the invention, a method is provided for treating a knee joint having connective tissue, including the iliotibial band, the biceps femoris, the peroneal collateral ligament, and the patellar tendon acting on the connective tissue; the method includes installing the prosthesis in a position to engage at least a portion of a connective tissue to alter a force vector applied by the connective tissue to the knee joint. Such exemplary methods may also include one or more of the following features or steps:

the prosthesis is installed without cutting the bone associated with the knee joint.

The knee joint has a joint capsule, and the prosthesis is mounted on a surface of the joint capsule.

The prosthesis displaces at least one connective tissue to change the force vector.

Connective tissue is displaced laterally and/or anteriorly.

The prosthesis alters the angle of the force vector relative to the knee joint.

The connective tissue is the iliotibial band, and the prosthesis displaces the iliotibial band in an lateral direction.

The connective tissue is the biceps femoris muscle, and the prosthesis displaces the biceps femoris muscle in an outward direction.

The connective tissue is the fibular collateral ligament, and the prosthesis displaces the fibular collateral ligament in a lateral direction.

The connective tissue is the patellar tendon, and the prosthesis displaces the patellar tendon in an anterior direction.

In a further exemplary embodiment of the present invention, a method of treating inflammation or pain caused by friction or pressure of soft tissue against other tissue is provided, comprising implanting a prosthesis in proximity to the soft tissue, wherein the prosthesis displaces the soft tissue sufficiently to reduce inflammation or pain. Such exemplary methods may also include one or more of the following features or steps:

the prosthesis displaces the soft tissue, thereby reducing the pressure of the soft tissue against other tissue.

The soft tissue is the iliotibial band.

The other tissue is the lateral femoral epicondyle.

The prosthesis is implanted between the tibia and the illiotibial band to laterally or anteriorly displace the illiotibial band.

Securing a prosthesis to the tibia.

The prosthesis is secured to the tibia adjacent to the tubercle.

Although the present invention is described by way of example in the context of various treatments of osteoarthritis and dysplasia in humans and animals associated with an imbalance of forces in the joints, it will be appreciated that the present invention may also be used to treat focal defects due to trauma or other causes. In particular, pain associated with focal defects in the medial condyle of the knee joint may be reduced by applying the devices and methods of the present invention to reduce the load on the medial condyle.

Other applications of the devices and methods of the present invention include the use of meniscal repair therapy in combination to reduce the load on the medial condyle. The iliotibial band has a contoured bearing surface that also reduces pain associated with iliotibial band friction syndrome. Another application includes the use of total hip replacement devices in combination to alter the mechanical forces acting on the new joint, thereby increasing the stability of the replacement joint and reducing the risk of graft wear. The present invention may further be adapted to displace tissue acting on various other joints, including elbow, shoulder, wrist, finger, spine, ankle, interphalangeal, jaw, or other joints, to reduce or otherwise alter loads in those other joints. For example, the implants of the invention may be configured to attach to the acetabulum, vertebra, scapula, humerus, radius, ulna, carpal bone, metacarpal bone, tarsal bone, metatarsal bone, talus bone, or other bones of the foot, among others.

Various embodiments are described above and in the accompanying drawings. It should be understood by those skilled in the art that various changes, omissions and additions may be made to that which is particularly disclosed herein without departing from the spirit and scope of the invention.